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IN STEREOLOGY
Wei Zhang, PhD
University of Pittsburgh, 2009
Stereology is the science that uses geometric probability to extract the internal quantitative
properties of a three dimensional object based on lower dimensional information. It is a
valuable research tool in biological science and relies heavily on statistical principles. In this
dissertation, we focus on studies that examine the number of neurons in a brain region of
interest using stereological techniques in order to compare subjects in different diagnostic
groups, e. g., subjects with schizophrenia and control subjects. A large number of counting
frames are usually used to obtain a prespecified precision for an individual in these kinds
of studies. Typically, researchers determine the number of counting frames for each indi-
vidual by controlling the coefficient of error for the individual. However, the researchers
from the Conte Center for the Neuroscience of Mental Disorders (CCNMD) at University of
Pittsburgh primarily focus on comparing biomarkers among different diagnosis groups rather
than evaluating individuals. A design goal for such stereological studies is to keep study cost
within budget and time constraints, while maintaining sufficient statistical power to address
the research aims. Statistical power can be increased by either adding more subjects or
more counting frames. And the cost of a study can be approximated by a linear combination
of the number of subjects and number of counting frames. To address this need, we have
developed new technologies that enable researchers to design a cost efficient study balancing
the number of subjects with the number of counting frames for each subject.
We also develop adaptive designs to conduct stereological studies. Adaptive designs allow
the opportunity to look at the data at an interim stage, and to modify the design based on
iv
the information obtained from the first stage data. In our adaptive design, we estimate
the stereological variance without breaking the blind of the Stage I data, and re-design the
second stage based on the stereological variance estimator obtained from the first stage.
Based on our procedure, we show researchers can cost-effectively modify the design while
maintaining the desired study power.
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1.0 INTRODUCTION
Psychiatrists and neuroscientists devote a considerable amount of effort to explore how bio-
logical structures in various brain regions of persons with mental diseases differ from those
in normal individuals. Studies in animals may also be used to detect the effects of phar-
macologic treatments on various types of brain cells in particular regions. Neuroscientists
in the Department of Psychiatry at the University of Pittsburgh often use post-mortem
tissue samples from the Brain Bank Core of the Conte Center for the Neuroscience of Men-
tal Disorder (CCNMD) to assess biological alterations in subjects with schizophrenia (e.g.,
Dorph-Petersen et al. (2007)), or to understand the neuropharmacologic effects of treatment
by performing animals studies (i.e., Konopaske et al. (2007), (2008)). The neurobiological
measurements, such as the number of particular type of neurons or cells, the volume of brain
regions and the density of specific cell types, are often the main focus of these studies. In this
dissertation, we concentrate on studies that examine the number of neurons in particular
brain regions. Neuron number (N ) is an important indicator of neurobiological alterations
in schizophrenia. A pathologic manifestation of schizophrenia appears to be reflected in the
reduction of the number of functional neurons in particular cortical regions. For example,
subjects with schizophrenia show deficits in visual perception and one of CCNMD studies
(Dorph-Petersen et al. 2007) found a substantial reduction in neuron number of the primary
visual cortex in the postmortem tissue from subjects with schizophrenia.
It would be an intractable task to physically count all the neurons of interest for a subject
in these types of studies. For example, there are about 2 ∼ 5 million neurons in the human
primary visual cortex (Dorph-Petersen et al. (2007)). Therefore, it is necessary to sample
tissue specimens to estimate the neuron number for an individual subject. Usually, the brain
regions to be analyzed are cut into sections in a systematic, uniformly random way, and
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then, counting frames within each section are also collected in a uniformly systematic way.
Stereological techniques are applied to estimate the number of particular type of neurons
or cells (N ) in the brain region of interest for a subject using the chosen sampling scheme.
Stereology uses geometric probability to extract the internal quantitative properties of a
three dimensional object based on lower dimensional information. In particular, stereological
procedures provide the mathematical and statistical framework for developing techniques and
methodologies for constructing estimates of various biological quantities (Jensen (1987)).
Unbiasedness considerations for stereological estimators were studied and discussed by Miles
and Davy (1976), Cruz-Orive (1980), Cruz-Orive and Weibel (1981), Jensen and Sunberg
(1986) and Jensen (1987). But to evaluate the precision of a stereological estimator when
the sampling scheme, as is typical, is based on uniform systematic samples is a complex
problem. There is no simple and exact formula for the stereological variance.
According to the typically used double systematic sampling scheme, the stereological
variance can be decomposed into two parts, between sections variance and within section
variance. The first part of the stereological variance depends on a covariogram function
which is defined by the true distribution of the neuron number in the region of interest.
Gundersen and Jensen (1987), Gundersen et al. (1999) gave two estimators of between sec-
tions variance based on two assumed simple forms of the covariogram. Determination of
the second part of the stereological variance depends on a two dimensional version of the
covarigram which is very difficult to obtain due to the irregularly shaped sections and insuffi-
cient information. In order to obtain an approximation of the second part of the stereological
variance, different procedures have been developed. In Cruz-Orive and Geiser (2004), the
authors suggest a Poisson model to fit stereological data.
From 2005 to 2007, Dr. Konopaske performed a series of studies (i.e., Konopaske et al.
(2007), (2008)) on chronic exposure of macaque monkeys with two antipsychotic treatments
to assess whether or not treatment with antipsychotic medication contributes to the distur-
bances in the number of neurons, glial cells and subtypes of glial cells in individuals with
schizophrenia. There were 18 male macaque monkeys (4.5-5.3 years of age) which were di-
vided into 3 experimental groups (n = 6 per group). Two experimental groups were treated
for 27 months with either haloperidol or olanzapine, and a third was given a sham treatment.
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Haloperidol is an antipsychotic medication that has been used for more than 50 years, while
olanzapine is a fairly new atypical antipsychotic. For each of several studies, Dr. Konopaske
and his colleagues spent a number of months collecting the data. In these studies, the sample
tissues are ready for use; however, they need to decide how much effort they should put in
measuring each subject before beginning a study.
In this dissertation, we further develop the statistical theory behind the current variance
estimator of Cruz-Orive and Geiser (2004) (Sections 2.2 and 2.3). Using the data that formed
the basis for the analysis in Konopaske et al. (2007), we illustrate the methodology (Section
2.4). We then show that the validity of the Poisson assumption of Cruz-Orive and Geiser
(2004) is questionable. The Poisson assumption may be appropriate for some cases but,
as we show, the Konopaske data indicates evidence of overdispersion relative to the Poisson
distribution (Section 2.4). This overdispersion of the data motivates us to find another model
which fits the data better. In our research, we investigate a special Cox process, called the
Ammeter process, to obtain a more accurate estimate of the stereological variance (Section
2.5). Basically, the Ammeter process is a Poisson process on R1 where the parameter λ is a
random parameter instead of a constant. To apply the idea of the Ammeter process to the
stereology setting, we extend the Ammeter process to a two-dimensional version to the tissue
section data to take into account the sampling features of stereology. Based on the Ammeter
process and the estimators of between section variance given by Gundersen and Jensen (1987)
and Gundersen et al. (1999), we obtain a new estimator of the stereological variance (Section
2.5). Then we use the maximum likelihood estimates (MLE) of the Ammeter process model
parameters to derive an improved stereological variance for the Konopaske data. In addition,
as a possible alternative approach to estimate the stereological variance, we briefly consider
a Bootstrap approach (Section 2.6). The stereological variance estimators obtained by the
Cruz-Orive and Geiser method and our two new approaches are compared in Section 2.7.
In Chapter 3, we focus on designing a stereological study, where one of the important
considerations is to select the appropriate number of subjects and number of sampling frames.
In a stereological study, researchers generally decide on the number of sampling frames that
are needed for each subject by what is required to precisely estimate the quantity of interest
for each tissue specimen for a given subject. They do so by controlling the coefficient of
3
error (CE = standard deviation / mean) of the stereological estimate of (N ) based on each
individual subject’s tissue sample. In Konopaske et al. (2007), about 1600 counting frames
were used for each animal and this took several months of work to prepare and observe
all the sampling frames using a microscope. For a setting where it is clinically required to
obtain the best estimate of a particular value for a given subject, it is reasonable to focus
on this level of accuracy. However, for studies designed for CCNMD, the interest is more
focused on comparing the biological measurements among different population groups. In the
statistical context, the aim of an experimental design is to ensure that comparisons among
the different populations are unbiased and, moreover, as precise and powerful as possible
given the experimental cost and time constraints.
Our ultimate goal is to develop a procedure for planning a cost efficient stereological
study. Statistical power can be increased by either adding more subjects or more sampling
frames. The cost of a study can be approximated by a linear combination of the number of
subjects and the number of sampling frames (Section 3.1.1). In our research, we consider
designs with a fixed power, and obtain an algorithm to find the the number of subjects and
the number of sampling frames that minimize the cost function (Section 3.1.3.1). Another
approach we obtain considers a fixed cost budget, and we provide the combination of subjects
and sampling frames that provide the maximum statistical power (Section 3.1.3.2). Because a
fairly standard CCNMD design is to use matched pairs, we simplify our power considerations
by examining in detail the paired t-test. In addition, one needs to consider the effect of
unequal stereological variances among groups under the alternative hypothesis.
To design a stereological study, we require the information about the magnitude of the
true stereological variance. However, as shown in Chapter 2, the stereological variance
depends on the shape of the region of interest and also on the neuron density. It is usually
difficult to prespecify the stereological variance before undertaking a study which focuses
on a particular type of neuron. To avoid inefficient use of the resources, we apply adaptive
design in the stereological studies to choose the optimal numbers of sampling frames to
maintain power and keep certain costs as low as possible. In Chapter 4, we first review some
existing literature on the topic of both blinded and unblinded adaptive designs (Proschan
and Hunsberger (1995), Gould and Shih (1998), Kieser and Friede (2001), Shun (2001) and
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Liu and Chi (2001)).
We use the approach of blinded adaptive procedures for stereological studies. Specifically,
in our adaptive approach, we only estimate the stereological variance without breaking the
blind of the Stage I data. We develop an approach that at the end of Stage I allows us
to update the assumptions about the stereological variance that were used in the planning
stage. In the setting, we consider the number of subjects is fixed, and we don’t stop the
study earlier. Based on the updated stereological variance, we change the number of counting
frames to be used in Stage II while maintaining the power. Because stereological variance of
the second stage differs from the first stage whenever the number of sampling frames changes
in Stage II, the statistical procedure used to test group effect needs to be handled with care.
In Section 4.3.5 we obtain an adjusted t-statistic to use for hypothesis testing at the end of
the study. We use simulation to show that the type I error rate of our procedure is protected.
5
2.0 STEREOLOGICAL ESTIMATE AND VARIANCE
Stereological methods extract the internal quantitative information of a three dimensional
object based on lower dimensional information. Stereology relies heavily on statistical princi-
ples, especially random sampling and sampling inference (Baddeley and Vedel Jensen (2005)).
In performing an experiment involving tissue sampling using tissue stereological techniques,
researchers usually decide on the number of sampling frames that are needed based on what
is required to precisely estimate the quantity of interest. The coefficient of error (CE =
standard deviation / mean) of the stereological estimate for the quantity of interest based
on a tissue sample is usually controlled to be about 5%. This criterion apparently grew
from the desire to estimate with precision the desired quantitative information for a specific
individual or patient. This has been carried over in studies which compare parameters based
upon samples from different populations. By this CE criterion, thousands of sampling frames
may be required for each individual, which can require researchers to do a large amount of
work requiring the use of programmable microscopes. For example, Dr. Konopaske per-
formed a series of studies in the Lewis lab from 2005 to 2007. He spent about four months
collecting data which consisted of about 25,000 observations (sampling frames) of cell types
in the 18 monkeys that were in each study. One of the studies that was completed in 2005 is
discussed in Section 2.4 in detail. The main goal of these studies in the CCNMD is always
to detect the possible neurobiological difference or the treatment effect between groups of
interest, which means that statistical inference about the population is more important than
the inference about an individual. More specifically, the subject to subject variability of the
primary outcome tends to be more important than the individual subject’s measurement
variability when we power stereological studies.
To do experimental design, we obviously need to connect the study power with the
6
stereological variability and the biological variability. To better understand the stereological
variability, we consider and evaluate stereological techniques carefully in this chapter.
2.1 STEREOLOGICAL SAMPLING AND STEREOLOGICAL
ESTIMATION FOR COUNTING
It is a well known fact that there are about a hundred billion neurons in a human brain.
Therefore, it is impossible to physically count all the neurons of a particular type in a region
of interest. It is necessary to sample tissues to estimate the number of neurons. Only
comparatively very small pieces of tissue can be observed. One of the standard sampling
schemes commonly used in stereology to count neurons or other cells within a region is
uniformly systematic sampling, which proceeds in multiple stages. A brain region of interest
with length L is exhaustively divided to M sections with thickness L
M
and m sections are
selected for the study. The location of the initial section related to the one end of the brain
region can for technical cutting reasons be viewed as having a uniform distribution on [0,
L
M
). The first sampled section is chosen from the first M
m
sections with equal probability. For
simplicity, we assume M is an integer multiple of m. We further assume X1 to be the position
of the first selected section relative to the one end of the brain region, and Xj = X1+(j−1) Lm ,
j = 2, . . . , m, to be the positions of the remaining m − 1 sections selected by systematic
sampling. Considering the inherent randomness of where the tissue of interest actually begins
in the first section physically cut, and the independently chosen the first sampled section,
the position of the first selected sample section can be viewed as uniformly randomly chosen
between 0 and L
m
, that is, X1 ∼ U [0, Lm), and Xj = X1 +(j−1) Lm , j = 2, . . . , m. The section
sampling fraction (τs) which is sampled using systematic sampling, is
m
M
. In Figure 2.1, the
ellipse in the left graph represents a three dimensional region of interest intersected by a
series of systematic uniform random cutting planes, represented by a set of lines. The graph
on the left represents a series of selected sections which are the grey stripes inside the ellipse.
The darkened regions in the right hand graph (Schmitz and Hof (2007)) are the brain region
of interest. In this example, a total of 50 sections (M = 50) were cut, and 10 sections (m =
7
10) were systematically selected. The first selected systematic sampling section is at 3L
50
and
then every fifth section (τs = 1/5) subsequently.
Figure 2.1: Section Sampling Fraction τs =
m
M
Second, a rectangular lattice grid, which has a fixed distance between cross lines called
the u-step (au) and the v-step (av), is randomly superimposed on each section. The same
u-step and v-step distances are used for all the sections within each individual. Within each
rectangular grid a smaller rectangle is that the number of particles can be obtained for that
smaller piece of tissue. This is done because the larger rectangular grid may include too
many cells to measure. Oftentimes, one chooses this smaller rectangular frame, which is
called the counting frame, to be the upper left corner of the rectangular grid, but in fact
it can be any consistent area within the rectangular grid. The physical frame examined
actually has depth and has a “cubic” structure, that is, it’s three dimensional. The size of
the rectangle is related to the area sampling fraction to be described shortly. The number
of rectangular grids determines the number of counting frames that can be obtained from
that tissue cross-section. Clearly, depending on the area of the cross-section, the numbers
of counting frames may differ from section to section. Furthermore, for a given section,
changing au and av will also change the number of counting frames. For each section j,
we define a random vector (U1j, V1j) as follows. Find the leftmost rectangular grid entirely
within the cross section. If two or more such rectangular grids exist, choose the uppermost.
For this specific grid, let U1j be the distance from the upper left corner to the tissue edge
moving along the u-direction, and V1j be the same in the v-direction. Then the counting
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frame for that grid is the upper-left smaller square, and all other counting frames are chosen
within any rectangular grid, as long as the upper left hand corner of the counting frame
remains within the tissue cross section. The set of upper-most left hand corners of these
counting frames is given by
Pj = {(U1j + kau, V1j + lav) : (U1j + kau, V1j + lav) ∈ Rj : k, l ∈ Z}
where Rj is the range of the j
th section, for j = 1, · · · ,m. The position (U1j, V1j) determines
Figure 2.2: Area Sampling Fraction τa = a
2
f/(au · av)
the position of the entire grid Pj in the jth section. Note that by construction, U1j, V1j can be
considered to be uniformly randomly selected within [0, au) × [0, av). The initial quantities
U1j and V1j for each tissue cross-section are chosen independently of each other and the
position of the first selected section X1. More specifically, (U11, V11), · · · , (U1,m, V1,m)|X1 =
x are conditionally i.i.d. according to (U, V ) ∼ Unif([0, au) × [0, av)) for any x. Hence
(U11, V11), · · · , (U1,m, V1,m) are independent of X1. The little black square in Figure 2.2
illustrates a counting frame with length af is chosen at the upper left corner of each rectangle,
and as noted is the specific tissue observed under the microscope. The area of the counting
frame is fixed and the area associated with each u, v step (au multiplied by av) is also
given. The area sampling fraction (τa) of this systematic sample can then be calculated as
9
a2f/(auav), and it is the same among all sections within each individual. Figure 2.2 gives
a two dimensional version of a cross-section with counting frames illustrated, and counting
frames selected within each cross-section is a two dimensional systematic random sampling.
Third, to allow unbiased counting rules based on the thick sections with thickness L
M
, a
smaller thickness h is examined in detail where h ≤ L
M
. The height of the counting frame is
assumed known relative to the thickness of the sections. The height sampling fraction (τh)
can then be calculated as h/ L
M
. The numbers of particular type of neurons or cells within
the selected counting frame between Xj and Xj + h are recorded. Figure 2.3 illustrates a
three dimensional version of a rectangle and a counting frame in Figure 2.2.
Figure 2.3: Height Sampling Fraction τh = h/
L
M
The micrograph in Figure 2.4 is from a study of the neuron number in the primary
visual cortex conducted by Dorph-Petersen et al. (2007). An image of a typical counting
frame is shown with a solid (red) exclusion line and a dotted (green) inclusion line. A
neuron is counted if: (1) its nucleolus is in focus fully or partially inside the counting frame
without touching the exclusion line, and (2) its nucleolus is fully or partially below the top
surface without touching the bottom surface. As shown in Figure 2.4, there are six typical
magnocellular neurons in total. The darker spot marked by “↑ ” within the neuron is the
nucleolus. In this micrograph, the two neurons in the middle with label “S” are counted.
The overall fraction of the brain region sampled from these three sampling fractions is
τs · τa · τh. The number of a particular type of neurons within a counting frame can be
obtained, using a programmable microscope for sampling and visualization of the particular
10
neurons of interest. Let Qj denote the total number of neurons actually counted by using
the microscope in the jth section of this selected random systematic sampling. The total
number of neurons actually counted in all of the counting frames is Q =
∑m
j=1Qj. Then the
total number of neurons in the region is estimated directly from
Nˆ = · 1
τs
· 1
τa
· 1
τh
Q. (2.1)
Nˆ is called the fractionator estimator, and is a primary outcome of the stereological studies.
The estimator Nˆ can be shown to be an unbiased estimator of the true total number of
neurons N irrespective of tissue shrinkage or swelling that may occur when the tissue is
processed (Dorph-Petersen et al. (2001)).
N - Neurons, S - Counted, ↑ - Nucleolus.
Figure 2.4: Image of a counting frame (Dorph-Petersen et al. (2007))
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2.2 THE DIFFICULTY OF VARIANCE ESTIMATION
From the theory of systematic sampling (Cochran (1977)), it is known that it is impossible
to develop an unbiased estimate of the stereological variance based upon a single system-
atic sample. Since the variance of the fractionator estimator is important for the studies
concerning group differences of the neurobiological measurements, we would like to better
understand the stereological variance. Based on the stereological sampling described in the
previous section, we have two systematic samples for each tissue block: the random system-
atic section sampling and the random systematic area sampling within a section. Therefore,
the stereological variation is from these two sources, which are called the between sections
variation and the within section variation. The first component is due to the random choice
of the first section, i.e., choosing X1, while the second component is due to the random choice
of the position of the first counting frame on the u and v axis, i.e., choosing (U1j, V1j), j = 1,
. . . , m, under the random systematic sampling method.
We now consider the stereological variance problem in further detail. In general, the true
number of a particular type of neurons can be represented as an integral of neuron’s density
function s(x, u, v) in three-dimensions:
N =
∫ L
0
{∫∫
(u,v)∈R(x)
s(x, u, v)dudv
}
dx, (2.2)
where s(x, u, v) is a density function of a particular type of neuron over the section at x, and
R(x) is the range of cross section values of (U, V ) at position x. To simplify the problem,
let us consider the problem of a one-dimension integral first,
N =
∫ L
0
f(x)dx, (2.3)
where f(x) is a nonnegative measurement function over the interval [0, L],
f(x) =
∫∫
(u,v)∈R(x)
s(x, u, v)dudv. (2.4)
The function f(x) represents the number of neurons at position x. Let X1 ∼ U [0, Lm)
and Xj = X1 + (j − 1) Lm . Then, if we were to measure f(x) without error at each of
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X1, X2, · · · , Xm, an approximation of the integral would be given by
N˜ = L
m
m∑
j=1
f(Xj)
=
L
m
m∑
j=1
f(X1 + (j − 1)L
m
). (2.5)
Since
E[N˜ ] =
∫ L
m
0
L
m
m∑
j=1
f(x1 + (j − 1)L
m
)
dx1
L
m
=
m∑
j=1
∫ L
m
0
f(x1 + (j − 1)L
m
)dx1
=
m∑
j=1
∫ j L
m
(j−1) L
m
f(x)dx
=
∫ L
0
f(x)dx
= N , (2.6)
N˜ is an unbiased estimator of N . Let fˆ(X1 + (j − 1) Lm , U1j, V1j) (which we abbreviate as
fˆj) be the estimator of the total number of neurons per unit of thickness at the section
determined by Xj given both X1 and (U1j, V1j) as the position of the first section and the
first counting frame, respectively. Thus, using the same argument as in Section 2.1, we have
fˆ(X1 + (j − 1)L
m
,U1j, V1j) =
1
τah
Qj, (2.7)
where Qj is the total number of neurons actually counted in all counting frames within the
section between Xj = X1 + (j−1) Lm and Xj +h = X1 + (j−1) Lm +h. Then the stereological
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estimate Nˆ in (2.1) can be denoted as,
Nˆ = 1
τs
· 1
τa
· 1
τh
m∑
j=1
Qj
=
1
m
M
1
τa
1
h
L
M
m∑
j=1
Qj
=
L
m
m∑
j=1
1
τah
Qj
=
L
m
m∑
j=1
fˆ(X1 + (j − 1)L
m
,U1j, V1j). (2.8)
By a similar argument to that in (2.6), we can show that Nˆ is an unbiased estimator of N .
By the standard variance decomposition, the variance of Nˆ is,
var[Nˆ ] = var[E(Nˆ )|X1] + E[var(Nˆ |X1)]
= var[E[
L
m
m∑
j=1
fˆ(X1 + (j − 1)L
m
,U1j, V1j]|X1]+
E[var[
L
m
m∑
j=1
fˆ(X1 + (j − 1)L
m
,U1j, V1j]|X1]. (2.9)
In (2.9),
E[
L
m
m∑
j=1
fˆ(Xj, U1j, V1j)|X1] = L
m
m∑
j=1
E[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1]
=
L
m
m∑
j=1
∫∫
(u,v)∈R(X1+(j−1) Lm )
s(X1 + (j − 1)L
m
, u, v)dudv
=
L
m
m∑
j=1
f(X1 + (j − 1)L
m
)
= N˜ , (2.10)
so that the first term in the right hand side of (2.9) is var[N˜ ].
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The second term on the right hand side of (2.9) is
E[var[
L
m
m∑
j
fˆ(Xj, U1j, V1j)|X1]] = E[(L
m
)2
m∑
j=1
var[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1]] (2.10a)
= (
L
m
)2
m∑
j=1
E[var[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1]] (2.10b)
= (
L
m
)2
m∑
j=1
E[var[fˆ(X1 + (j − 1)L
m
,U, V )|X1]] (2.10c)
= (
L
m
)2
m∑
j=1
∫ L
m
0
var[fˆ(x1 + (j − 1)L
m
,U, V )|x1]dx1L
m
(2.10d)
=
L
m
m∑
j=1
∫ j L
m
(j−1) L
m
var[fˆ(x, U, V )|x]dx (2.10e)
=
L
m
∫ L
0
var[fˆ(x, U, V )|x]dx, (2.10f)
where (2.10a) follows from fˆ(X1 + (j − 1) Lm , U1j, V1j) being independent of fˆ(X1 + (k −
1) L
m
, U1k, V1k), j 6= k, for given X1. Since (U11, V11), · · · , (U1,m, V1,m) are i.i.d. according to
(U, V ) ∼ Unif([0, au)× [0, av)), (2.10c) follows from the fact that the marginal distribution
of U, V |X does not depend on X. (2.10d) follows from the uniform distribution of X1; and
(2.10e) follows from a change of variables.
Hence, combining (2.10) and (2.10f), we obtain
σst = var[N˜ ] + L
m
∫ L
0
var[fˆ(x, U, V )|x]dx, (2.11)
where we use σst as the notation of the stereological variance of the stereological estimator
Nˆ , and where σst1 and σst2 are respectively the notation for the first and second component
terms of the stereological variance in (2.11). Note that the between-section variance σst1
is the same as the variance of N˜ . The estimation of the between section variance can be
examined by considering the variation of approximating the integral of function f(x) over the
interval [0, L] using a systematic sample. To calculate this variance, usually the covariogram
function gf (t) defined by (2.12) is introduced. The within section variance σst2 is the integral
over X of the conditional variance of fˆj given X1 = x and is determined by the shape of the
density function s(x, u, v) in the jth section, j = 1, . . . ,m. Note that this quantity depends
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on the conditional distribution of U1j, V1j|X1. As we later discuss, to compute this variance
would require a notion of a two dimensional covarigram over a complex region, so other
approaches are needed. To be clear, even if we know the true value of f(Xj), which means
the second term on the right hand side of (2.11) is zero, there is still variation in terms of
var[N˜ ].
To calculate the between section variance, var[N˜ ], we need the covariogram function
gf (t) defined as
gf (t) =

∫ L−t
0
f(x+ t)f(x)dx 0 ≤ t ≤ L∫ L
−t f(x+ t)f(x)dx −L ≤ t ≤ 0
0 otherwise.
(2.12)
the function gf (t) reflects in some sense the correlation of the measurement function f
between two slices separated by a distance t.
Then var[N˜ ] is given by
var[N˜ ] = L
m
gf (0) + 2
L
m
m∑
l=1
gf (l
L
m
)− 2
∫ L
0
gf (y)dy, (2.13)
(see Correa (2001)).
A standard simplifying assumption is that gf (t) has the form at
2 + bt + c, b < 0 (see
Gundersen and Jensen (1987)). Then it can be shown that
var[N˜ ] = −1
6
(
L
m
)2b. (2.14)
Alternatively, if it is assumed that gf (t) has the form b3t
3 + b2t
2 + b0 (see Gundersen et al.
(1999)), then it can be shown that
var[N˜ ] = 1
60
(
L
m
)4b3. (2.15)
We denote the variances in (2.14) and (2.15), respectively, by σast1[N˜ ] and σbst1[N˜ ], both
of which can be viewed approximations of σst1. The standard approach is to approximate
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the covariogram function gf (t) at 0,
L
m
, 2 L
m
, · · · , (m− 2) L
m
by ĝf (t), where
ĝf (k
L
m
) =
L
m
m−k∑
j=1
fjfj+k. (2.16)
To estimate the coefficients a, b and c in the quadratic function and to obtain an estimate
of σast1[N˜ ], the standard approach uses, the estimates of the first three covariogram terms
and solves
ĝf (0) = cˆ,
ĝf (
L
m
) = aˆ(
L
m
)2 + bˆ(
L
m
) + cˆ,
ĝf (2
L
m
) = 4aˆ(
L
m
)2 + 2bˆ(
L
m
) + cˆ. (2.17)
The solution for b can be obtained as
bˆ = −3ĝf (0)− 4ĝf (
L
m
) + ĝf (2
L
m
)
2 L
m
, (2.18)
and hence, we estimate σst1 by
σ̂ast1[N˜ ] =
L2
12m2
(3
m∑
jˆ=1
f 2j +
m−2∑
j=1
fjfj+2 − 4
m−1∑
j=1
fjfj+1), (2.19)
where fj = f(Xj, U1j, V1j), Xj = X1 + (j − 1) Lm , and j = 1, . . . ,m.
Similarly, we can obtain the solution for b3 in (2.15) as
b̂3 =
3ĝf (0)− 4ĝf ( Lm) + ĝf (2 Lm)
4( L
m
)3
, (2.20)
so that, we can also estimate σst1 by
σ̂bst1[N˜ ] =
L2
240m2
(3
m∑
j=1
f 2j +
m−2∑
j=1
fjfj+2 − 4
m−1∑
j=1
fjfj+1), (2.21)
where fj = f(Xj, U1j, V1j), Xj = X1 + (j − 1) Lm , and j = 1, . . . ,m.
We now consider in further detail the second term in the right hand side of the variance
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formula (2.11). Recall that
f(x) =
∫∫
(u,v)∈R(x)
s(x, u, v)dudv, (2.22)
so that
fˆ(Xj, U1j, V1j)
= axay
∑∑
{k,l:(U1j+(k−1)ax,V1j+(l−1)ay)∈Rj}
s(Xj, U1j + (k − 1)ax, V1j + (l − 1)ay),
j = 1, . . . ,m. (2.23)
Hence by extending the approximations underlying (2.5) and (2.6) to a two dimensional
systematic sample, we have that fˆ(Xj, U1j, V1j) is an unbiased estimator of f(Xj). From
the random systematic sample and the idea of the one dimensional covariogram we see that
the between section variation is a function of the density function s(x, u, v). To compute
var[fˆ(X1 + (j− 1) Lm , U1j, V1j)|X1], we need a two-dimensional version of covariogram and a
method to deal with the problem of irregularly shaped sections. It is very difficult to work
with a two dimensional covariogram. Furthermore, to actually estimate the within section
variance, a bivariate polynomial would be needed to approximate the bivariate covarigram
in the spirit that Gundersen and Jensen (1987) and Gundersen et al. (1999) did for the
univariate case.
To avoid using the two dimensional version of the covariogram function g∗s(x, y), Cruz-
Orive and Geiser (2004) tried to make some simplifying assumptions on the neurons’ distri-
bution within the sections, which we discuss in the following section.
2.3 CRUZ-ORIVE AND GEISER’S STEREOLOGICAL VARIANCE
ESTIMATOR
Cruz-Orive and Geiser (2004) stated that no simple formula has been developed for the esti-
mator of the second component of the stereological variance. In fact, they note in their paper
that the estimation of the within section variance based on a two dimensional systematic
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sample was viewed by Cruz-Orive (1999) as an open problem. To avoid the problem of a two
dimension covariogram function applied on a irregularly shaped section, Cruz-Orive and
Geiser (2004) made the following approximation. Let nj be the number of counting frames
in the jth section and Qjk be the observed number of neurons in the k
th counting frame of
the jth section, k = 1, . . . , nj, j = 1, . . . ,m, so that
Qj =
nj∑
k=1
Qjk (2.24)
is the total number of neurons observed in the jth section. Let
K =
m∑
j=1
nj (2.25)
denote the total number of the counting frames in all sections.
They assume that given the first position of X1, the numbers of neurons in each counting
frame in the jth section are i.i.d from a Poisson distribution with parameter λj, i.e., for
each j, that is Qjk|X1, k = 1, · · · , nj ∼i.i.d Poisson(λj). As the counting frames all have
equal size, then Qj|X1, j = 1, · · · ,m,∼indep Poisson(njλj). Their assumption requires that
neurons follow a homogeneous process over the region of interest.
Since the Poisson distribution is independent of the location, this means Qjk is indepen-
dent of U1j and V1j.
Thus, within the jth section,
var[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1] = 1
τ 2ah
2
var[Qj] =
1
τ 2ah
2
nj∑
k=1
var[Qjk] =
1
τ 2ah
2
njλj, (2.26)
so that the ML estimator of the variance is
v̂ar[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1] = 1
τ 2ah
2
Qj. (2.27)
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Hence, Cruz-Orive and Geiser (2004) obtained the following estimator of σst2
σ̂C−Ost2 =
L2
m2
m∑
j=1
v̂ar[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1]
=
L2
m2
1
τ 2ah
2
m∑
j=1
Qj
=
1
τ 2s τ
2
a τ
2
h
Q. (2.28)
Combined with the between section variance estimator (2.19) or (2.21), Cruz-Orive and
Geiser then provided an estimate of the stereological variance σst.
2.4 MOTIVATING DATA
In 2005, Dr. Konopaske performed a study on chronic exposure of macaque monkeys with
two antipsychotic treatments to assess whether or not treatment with antipsychotic med-
ication contributes to the disturbances in the number of a particular type of cells, called
glial cells, previously observed in individuals with schizophrenia (Konopaske et al. (2007)).
In Konopaske’s study, there were 18 male macaque monkeys which had been divided into 3
experimental groups (n = 6 per group): haloperidol, olanzapine and sham, where the mon-
keys were matched across experimental groups as triples. Actually a more simplified cutting
scheme uses large slabs cut initially to make the small width sections cuts feasible and at
the same time produce sections which follow the model. For each monkey, the parietal lobe
was cut in a systematic, uniformly random manner producing 12 ∼ 15 slabs (m = 12 ∼ 15)
with a mean width of L
m
= 2.5mm(= 2500µm). The thickness of a small width section is
80µm. There are about 31 small width sections for each slab, which yield approximately 375
to 469 small width sections for the entire region when the sampled sections are viewed to
be exhaustively cut from the region. The section sampling fraction is 0.0320 (= 80/2500).
The area of the counting frames is always kept as 219.7µm2. The length of u-step (au) and
v-step (av), au = av, was kept constant within each monkey, but may differ across monkeys,
varying from 700 to 900 µm. Dr. Konopaske has kindly provided us access to the individual
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counting frame data from this study, where the number of glial cells was counted in each
counting frame.
Uneven shrinkage in section thickness can introduce biases when using the classical opti-
cal fractionators (West and Gundersen (1991)). However, such potential biases are eliminated
by using the optical fractionators based on a mean section thickness that is number-weighted
(t¯Q) (Dorph-Petersen et al. (2001)). Mean section thickness is number-weighted as follows:
t¯Q = (
∑
j
∑
k(tjkQjk))/(
∑
j
∑
kQjk) where tjk is the local section thickness of the j
th section
and kth counting frame having a count of Qjk. The height of the counting frame is fixed,
h = 8µm. Total cell numbers were estimated as:
Nˆ = 1
τs
· 1
τa
· 1
τh
·Q, (2.29)
where the section sampling fraction (τs) is
m
M
, the area sampling fraction (τa) is
a2f
axay
, the
height sampling fraction (τh) is
h
t¯Q
, and Q is the number of neurons counted in all sampled
counting frames.
We now apply the Cruz-Orive and Geiser (2004) method to estimate the stereological
variance, using monkey #256 as an example. For monkey #256, 12 sections and 1626
counting frames in total were sampled and these data are provided in Table 2.1. The length
of the u-step and v-step are 750 µm and the mean counting frame thickness is 32.5 µm.
The fractions τs, τa and τh were 0.0320 (= 80/2500), 0.0004 (= 219.7/(750*750)) and 0.4065
(= 8/19.7), respectively. A total of 931 neurons were counted in all the sampled counting
frames, so that the estimated number of the glial cells in the parietal lobe by (2.29) was
Nˆ = 1
τs
· 1
τa
· 1
τh
·Q = 1
0.0320
· 1
0.0004
· 1
0.4065
· 931 = 183.2 · 106.
Applying (2.21) and (2.28) to calculate the between and within section variance, respectively,
we obtain the stereological variance estimator for monkey #256 as
σ̂st =
1
240
1
τ 2s τ
2
a τ
2
h
[(3
m∑
j=1
Q2j −Q)− 4
m−1∑
j=1
QjQj+1 +
m−2∑
j=1
QjQj+2] + (
1
τsτaτh
)2Q = 36.8 · 1012.
Table 2.1 gives the section data of monkey #256.
In this study, there were more than 30,000 counting frames collected over the 18 ani-
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Table 2.1: Details for the Stereological Variance Formula: Monkey #256 (Konopaske et al.
(2007))
Section nj Qj Q
2
j QjQj+1 QjQj+2
1 42 25 625
2 77 46 2116 1150
3 92 56 3136 2576 1400
4 89 38 1444 2128 1748
5 95 44 1936 1672 2464
6 141 70 4900 3080 2660
7 181 85 7225 5950 3740
8 245 150 22500 12750 10500
9 218 145 21025 21750 12325
10 212 126 15876 18270 18900
11 177 107 11449 13482 15515
12 57 39 1521 4173 4914
Total 1626 931 93753 86981 74166
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mals. Of interest to us was to examine whether the necessary Poisson assumption is valid
to use Cruz-Orive and Geiser’s approximation for the stereological variance models holds.
To do this, we examined whether or not the Poisson assumption holds within each section
for all animals. As we show, our results indicate that the Poisson assumption seems not
to be appropriate. We considered typical examples of three monkeys, one from each group:
monkey #256 from olanzapine, #261 from sham and #263 from haloperidol group. In Table
2.2 for each monkey, the variables in the first three columns are: animal ID (ID), section
number (Section), and number of sampled counting frames for each section (nj). For each
corresponding section, the fourth to fifth columns are the sample mean Q¯j over counting
frames within that section, and the sample variance s2j over counting frames of the number
of the glial cells for each corresponding section. The sixth column shows the ratio of the
variance to the mean (s2j/Q¯j), which under the Poisson distribution assumption should be
approximately equal to 1.0. The variances within each section, however, are about 10-20
percent larger than the means. This suggests that the data have more variability within
each section than the Poisson distribution predicts. Additionally, Pearson χ2 goodness-of-fit
tests are used to check the Poisson assumption and the corresponding p-values obtained by
using Pearson χ2 goodness-of- fit for each section are listed in the last column (p-value) of
Table 2.2. The goodness-of-fit test shows that in about 50% of the sections the p-values are
less than 0.10. Thus, our analyses suggest that we would be underestimating the true vari-
ability by using the Cruz-Orive and Geiser method. This motivates us to seek an approach
to better fit the data.
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Table 2.2: Validation of Poisson Assumption
ID Section nj Q¯j s
2
j s
2
j/Q¯j p-value
1 42 0.595 0.686 1.15 0.783
2 77 0.597 0.848 1.42 0.123
3 92 0.609 0.724 1.19 0.160
4 89 0.427 0.361 0.85 0.069
5 95 0.463 0.421 0.91 0.384
256 6 141 0.497 0.780 1.23 0.031
7 181 0.470 0.650 1.39 0.010
8 245 0.612 0.755 1.23 0.012
9 218 0.665 0.887 1.33 0.483
10 212 0.594 0.754 1.27 0.022
11 177 0.605 0.899 1.49 0.011
12 57 0.684 0.719 1.05 0.832
1 31 0.871 0.983 1.13 0.728
2 48 0.583 0.546 0.94 0.650
3 62 0.548 0.481 0.88 0.806
4 72 0.583 0.725 1.24 0.664
5 81 0.457 0.726 1.59 0.015
6 103 0.621 0.904 1.46 0.023
7 124 0.589 0.832 1.41 0.029
261 8 176 0.534 0.799 1.50 0.014
9 230 0.504 0.522 1.03 0.075
10 169 0.521 0.549 1.05 0.968
11 239 0.557 0.718 1.29 0.001
12 152 0.599 0.811 1.36 0.061
13 88 0.659 0.664 1.01 0.415
Note, the p-values listed in the last column are obtained by using Pearson χ2 goodness-of- fit.
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ID Section nj Q¯j s
2
j s
2
j/Q¯j p-value
1 12 0.500 0.455 0.91 0.818
2 50 0.360 0.398 1.11 0.711
3 71 0.592 0.617 1.04 0.736
4 86 0.372 0.425 1.14 0.355
5 110 0.473 0.490 1.04 0.928
263 6 144 0.583 0.720 1.23 0.028
7 156 0.615 0.754 1.23 0.005
8 146 0.699 1.053 1.51 0.092
9 185 0.578 0.713 1.23 0.133
10 299 0.448 0.517 1.15 0.199
11 195 0.564 0.660 1.17 0.071
12 116 0.509 0.896 1.76 0.006
Note, the p-values listed in the last column are obtained by using Pearson χ2 goodness-of- fit.
2.5 AMMETER PROCESS
Due to Konopaske’s data not conforming to the assumption of a Poisson point process, we
would like to find a stochastic point process that would more appropriately fit the data. Since
the counting frame data within sections are collected by a systematical sampling scheme,
ideally we would like to find a non-homogeneous Poisson process which is independent of the
location to avoid the use of two-dimensional covariogram; however, no such process exists.
Instead we suggest the use of a special Cox process which appears to fit the data better than
the Poisson.
A Cox process with a piecewise constant intensity, sometimes called an Ammeter process,
is a Poisson process where λ is generated from a random variable instead of being constant
(see Grandell (1997)). Consider a one dimensional range of interest, and assume that there
are K fixed known mutually exclusive sub-range intervals L1, L2, . . . , LK . Let λ1, λ2, . . . , λK
be i.i.d from a common distribution U . Then the process given λ1, λ2, . . . , λK is a Poisson
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process for each sub-range where the process with intensity parameter λk over the interval
Lk, that is,
λ(t) = λk for t ∈ Lk, k = 1, . . . , K. (2.30)
Denote E[λk] by µA and var[λk] by σ
2
A. An instance of the intensity process in the Ammeter
process is illustrated in Figure 2.5.
Figure 2.5: Illustration of the Intensity in the Ammeter Process
For application to the tissue section data, we need to extend the Ammeter process
to a two dimensional version. For the range of interest, we assume that there are I ∗ K
fixed known mutually exclusive square sub-ranges L11, L12, . . . , LIK having common square
length L. Let λ11, λ12, . . . , λIK be i.i.d from a common distribution U . Then the process
given λ11, λ12, . . . , λIK is a two dimensional Poisson process for equal area size with intensity
parameter λik over the square Lik, that is,
λ(t) = λik for t ∈ Lik, i = 1, . . . , I and k = 1, . . . , K. (2.31)
Denote E[λik] by µA and var[λik] by σ
2
A.
If the grid length used under the microscope is approximately the same the common
square length L in the Ammeter process, then each systematic sample falls within the square
[iL, (i+1)L]× [kL, (k+1)L]. Moreover, this assumption is still valid, if L is ρ times the grid
length where ρ is an arbitrary positive integer. With these assumptions we can recalculate
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the within section variances based on the Ammeter process assumption. Without these
assumptions, there is the possibility that the counting frame would fall across two or more
sub-ranges, vastly complicating the distribution theory. However, the ratio of the area of the
counting frames to the area of the rectangle is very small, which is about 1/2000, so there
is very little possibility that this happens. The estimate Nˆ of the number of neurons would
be given by the same formula as (2.1), and the estimate is an unbiased estimator of N .
To estimate the stereological variance, we calculate the between section variation by
(2.19) or (2.21), only change the calculation of the within section variation.
If we assume that P , the number of neurons counted in a counting frame, follows the
Ammeter process and the distribution of the intensity U is a Gamma distribution, then P
would follow a negative binomial (NB) distribution. The distribution of the resulting P can
be expressed in terms of a mean µ and a dispersion parameter φ, so that the probability of
observing q neurons is
Pr(P = q) =
Γ(φ+ q)
q!Γ(φ)
(
µ
µ+ φ
)q(1 +
µ
φ
)−φ. (2.32)
The variance of this NB distribution is µ(1 + µ
φ
). When φ → ∞, the NB distribution
converges to a Poisson distribution. The maximum likelihood (ML) estimator µˆ of µ is the
sample mean, and the ML estimator φˆ of φ is determined by numerical maximization of the
profile log-likelihood function L(µˆ, φ).
Under the Ammeter process assumption, if we assume that Qjik, the observed values
within the counting frame, in the square Lik of the j
th section follow a NB distribution with
parameters (µAj, φAj), then we have
var[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1] = var(
∑
i,k
1
τah
Qjik)
=
1
τ 2ah
2
njµAj(1 +
µAj
φAj
). (2.33)
The MLE of µAj is
∑
i,kQjik/nj = Qj/nj. Combining the MLE of var[fˆ(X1 + (j −
1) L
m
, U1j, V1j)|X1] in (2.33) with the between section variance estimator (2.19) or (2.21), the
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stereological variance in (2.11) turns out to be
σ̂st = σ̂st1 +
L2
m2
var[fˆ(X1 + (j − 1)L
m
,U1j, V1j)|X1]
= σ̂st1 +
L2
m2
1
τ 2ah
2
m∑
j=1
njµˆAj(1 +
µˆAj
φˆAj
)
= σ̂st1 +
1
τ 2s τ
2
a τ
2
h
m∑
j=1
Qj(1 +
Qj
njφˆAj
). (2.34)
The Ammeter based estimators of the variance are included in Table 2.3. In Section 2.7,
we compare these variances with the stereological variances obtained under several different
procedures.
2.6 BOOTSTRAP METHOD TO ESTIMATE THE STEREOLOGICAL
VARIANCE
The bootstrap method can be applied to estimate the stereological variance. Without any
distributional assumption, using section as a stratifying variable, independent bootstrap
samples can be selected within the sections based on sampling the counting frame counts
with replacement. It is clear that for homogenous processes and “partially” homogenous
process like Ammeter for neuron development that the bootstrap variance will tend to
overestimate the true variance derived based on the process.
For example, if we have 12 sections, with nj counting frames in the j
th section, let
X = (x1,1, x1,2, . . . , x1,n1 , . . . , x12,1, . . . , x12,n12) denote the counting frame level data, so that
xjk is the number of neurons counted in the j
th section of the kth counting frame. A boot-
strap sample, X∗ = (x∗1,1, x
∗
1,2, . . . , x
∗
1,n1
, . . . , x∗12,1, . . . , x
∗
12,n12
), is chosen where x∗j,1, . . . , x
∗
j,nj
are selected independently with replacement from
{
xj,1, . . . , xj,nj
}
, j = 1, 2, . . . , 12. From
the bootstrap sample, we can accordingly estimate the total number N ∗. We then simu-
late B independent bootstrap samples X∗1, X∗2 . . . , X∗B and obtain stereological estimates
Nˆ ∗1, Nˆ ∗2 . . . , Nˆ ∗B, respectively. Then the within section variance of the stereological esti-
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mate of Nˆ (σ̂BSst2 ) can be estimated by
σ̂BSst2 = var[Nˆ ∗], (2.35)
where var[Nˆ ∗] is the sample variance of B stereological estimates. Combined with the
between section variance estimator (2.19) or (2.21), the estimated stereological variance in
(2.11) turns out to be
σ̂BSst = σ̂st1 + var[Nˆ ∗]. (2.36)
2.7 COMPARING THE STEREOLOGICAL VARIANCE ESTIMATES
Using the Konopaske data, we compare the stereological variance estimates calculated by
the three different methods. Table 2.3 lists the results for each animal. The column σ̂st1 is
the first component of the stereological variance estimator based on (2.21). The columns
σ̂C−Ost2 , σ̂
AM
st2 and σ̂
BS
st2 give the second component of the stereological variance estimator based
on the Cruz-Orive and Geiser assumption, Ammeter assumption and Bootstrap approach,
respectively. The column σ̂C−Ost is the sum of σ̂st1 and σ̂
C−O
st2 , which is the stereological
variance estimator by the Cruz-Orive and Geiser method. The next column σ̂AMst is the sum
of σ̂st1 and σ̂
AM
st2 , which is the stereological variance estimator by the Ammeter method. The
last column σ̂BSst is the sum of σ̂st1 and σ̂
BS
st2 , which is the stereological variance estimator by
the Bootstrap method. Note that when comparing between sections variation with within
sections variation, the between section variance estimator σ̂st1 shows much less section-to-
section variability than within section variability as shown by the estimators σ̂C−Ost2 , σ̂
AM
st2 or
σ̂BSst2 . The literature indicates that treating random systematic samples as simple random
samples will overestimate the variability. Here, the Bootstrap method treats the counting
frames as simple random samples within sections, and the stereological variance seems to
be overestimated by the Bootstrap method perhaps because of the positive dependence
between counting frames within sections. On the other hand, as our analysis summarized
in Table 2.2 indicates, we believe that for the Konopaske data, the stereological variance is
underestimated by the Cruz-Orive and Geiser method. Note that the stereological variance
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estimators given by the Ammeter method are between these other two methods in most of
the cases. In Table 2.3, we also provide the stereological estimate, the total counted number
of neurons and the coefficient of error (under Cruz-Orive and Geiser assumption) for each
animal (Columns Nˆ , Q and CE, respectively).
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Table 2.3: Comparison of Estimates of the Stereological Variance (Konopaske et al. (2007))
ID Triad Group Nˆ Q CE σ̂st1 σ̂C−Ost2 σ̂AMst2 σ̂BSst2 σ̂C−Ost σ̂AMst σ̂BSst
260 1 H 141.9 862 0.036 2.4 23.3 27.2 27.6 25.7 29.6 29.9
273 2 H 121.1 525 0.044 0.1 28.0 32.2 33.0 28.0 32.3 33.1
257 3 H 132.1 661 0.040 1.3 26.4 30.7 35.1 27.7 32.0 36.4
266 4 H 170.6 805 0.037 3.9 36.2 42.8 43.8 40.1 46.7 47.7
270 5 H 125.1 607 0.041 0.6 25.8 30.7 32.0 26.4 31.3 32.6
263 6 H 169.9 842 0.035 0.4 34.3 42.9 43.0 34.7 43.3 43.5
259 1 O 165.4 845 0.035 1.5 32.4 37.1 38.5 33.9 38.7 40.0
274 2 O 159.3 734 0.037 0.6 34.6 39.9 38.7 35.2 40.5 39.3
256 3 O 183.2 931 0.033 0.8 36.1 45.9 50.7 36.8 46.7 51.5
267 4 O 138.8 769 0.037 0.8 25.1 29.5 28.7 25.8 30.2 29.5
271 5 O 140.6 771 0.040 5.9 25.6 29.9 31.6 31.5 35.8 37.5
265 6 O 155.5 766 0.036 0.5 31.6 39.5 37.3 32.1 40.0 37.8
261 1 S 192.0 885 0.034 1.7 41.7 52.1 61.0 43.3 53.8 62.7
272 2 S 153.7 737 0.037 0.5 32.1 36.5 37.6 32.6 37.1 38.1
258 3 S 214.9 916 0.034 2.0 50.4 60.3 66.6 52.4 62.2 68.5
268 4 S 122.3 630 0.040 0.2 23.8 27.1 27.8 24.0 27.3 28.0
269 5 S 196.1 772 0.037 3.1 49.8 58.5 61.4 52.9 61.6 64.5
264 6 S 172.5 750 0.037 1.4 39.7 49.1 49.9 41.1 50.5 51.3
Note: H, O and S denote for the haloperidol, olanzapine and sham group, respectively. The units for Nˆ is 106 and the units for σ̂st1, σ̂C−Ost2 , σ̂AMst2 ,σ̂BSst2 ,
σ̂C−Ost , σ̂AMst , σ̂
BS
st are 10
12 in the Table 2.3.
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Table 2.4 lists the summary statistics for the Konopaske data by groups. The biological
variance is estimated by subtracting the stereological variance from the average of group
variances. The stereological variance (by the Cruz-Orive and Geiser method) is estimated
by averaging columns σ̂C−Ost2 in Table 2.3 as 34.7. The estimated variance of the primary
experimental outcome, Nˆ , is based on the pooled variance, 620.7, (average of the three within
group variances). Hence, the average biological variance is 586.0 (= 620.7 - 34.7). We see
that the stereological variance is small relative to the biological variance. In implementing
experimental designs like this, researchers usually choose the number of counting frames
for each subject by controlling the coefficient of error (CE) of the stereological estimate
for each subject, in an attempt to assess each individual as precisely as possible. Usually,
they require the CE to be less than 5%. To meet this criterion for the monkey study, Dr.
Konopaske and his colleagues had to collect about 1600 counting frames for each animal.
If the number of counting frames could have been reduced, the research studies could have
saved several months’ laboratory work. This motivates us to consider in the next two sections
more efficient experiment designs which still maintain enough power to detect the treatment
effects of interest. For the biological experiments which test between groups differences,
usually the between-subject variation is larger than within subject variation mainly due to
stereological procedures. Thus a reasonable allocation of sampling effort is to sample a large
number of subjects and spend relatively little effort on measuring the data in each subject.
Gundersen and Osterby (1981) were aware of this reality and described it as “Do More, Less
Well”.
Table 2.4: Summary of Konopaske’s Data.
Group Number Mean Variance
Haloperidol 6 143.46 480.05
Olanzapine 6 157.14 273.24
Sham 6 175.30 1108.89
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3.0 OPTIMAL DESIGN
For obvious reasons of budgetary and time constraints, a goal of research in designing
post-mortem tissue stereological studies is to keep study cost within budget and time con-
straints while maintaining sufficient statistical power to address the research aims. While
the Konopaske study used tissue from a previous study, one could imagine designing a new
monkey study for the sole purpose of a study like Konopaske. For such a study, we note that
macaque monkeys are expensive study subjects, and that numerous labor hours could be
involved in creating and observing the counting frames from each animal. One could reduce
the cost of studies like this by decreasing either the number of subjects or the number of
counting frames for each subject. Increasing the number of counting frames yields more
precise estimates of the neuron number for each animal, and hence increases study powers.
One trade-off would be to reduce the number of subjects, and then add counting frames for
each subject in order to maintain the study power. Alternatively, one could increase the
numbers of subjects and reduce the numbers of counting frames per subject to maintain
power. There appears to be little written in the stereology literature about how to select the
combination of sample size and numbers of counting frames for stereological study designs.
The purpose of this chapter is to create a framework for finding the combination of sample
size and number of counting frames that will not only maintain sufficient power to address
research aim but also minimize the cost of the study.
There is established methodology for general repeated measure designs which deal with
optimal trade-offs between sampling units and replicates for each sample. (For instance, see
Liu and Liang (1992), Mentre et al. (1997), Vickers (2003)). Most of this work focuses on
the covariance structure of the repeated measures. However, this literature is not directly
applicable to the stereological problem due to several specific difficulties that become ap-
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parent as we describe our research. In stereological studies dealing with counting, the first
component of the stereological variance is always unchanged, so that one thing we can do
to maintain power is to change the number of counting frames in order to adjust the within
section variance. Also, we need to take into account the possibility that the stereological
variances are different between groups.
3.1 MATHEMATICAL APPROACH
3.1.1 Cost Function and Power Function
We begin by using the idea of some standard designs employed in the CCNMD, where
we want to compare two groups by using a simple linear model for testing, which for power
considerations can be well approximated by a paired t test. In order to control for covariates,
in human studies for example, each experimental subject and corresponding control subject
are matched by covariates, such as age at death, gender, post-mortem interval and brain pH
value. Pairing also helps to reduce variability due to tissue processing designs, a topic we
don’t discuss further here. A consideration of experimental design takes into account the
stereological variance. Using the results described in Chapter 2 concerning the stereological
variance, we discuss in Section 3.1.2 the amount of increase in the stereological variance
caused by decreasing the number of counting frames. Then taking into account the subject-
to-subject biological variability, we introduce in this section a linear cost function and also a
power function, both of which depend on the number of subjects and the number of counting
frames.
We consider a paired analysis to compare the difference of the number of neurons between
two groups, control and treatment (or experimental). Let N be the number of pairs used
in the study and K be the number of counting frames collected for each subject, assuming
each subject has the same number of counting frames. We define a cost function as follows:
Cost(N,K) = C0 + 2C1N + 2C2NK. (3.1)
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In the cost function, C0 is the setup cost for a study. C1 is the cost for each subject, i.e.,
the cost of tissue preparation in a post-mortem tissue study; in the animal studies, also
including animal cost, treatment cost and nursing cost. We assume the cost is the same
for each subject in the treatment group and control group. C2 is the cost for each counting
frame which includes constructing the counting frame, delineating the appropriate neurons
and counting them. Since C0, C1 and C2 are positive constants, it is sufficient to know the
relative cost C1/C2 in order to minimize the study cost. Invariably the subject cost C1 is
relatively large compared to the counting frame cost C2 .
We now provide a model for analyzing a paired study using paired differences. Let Xik be
the true number of neurons of subject k in group i, i = c (control group) or i = t (treatment
group), k = 1, · · · , N , then the typical model in such a study assumes
Xik ∼i.i.d N(µi + pk, σB), (3.2)
where µi is the mean of group i, pk is the effect of pair k (with
∑N
k=1 pk = 0) and σB is
the biological variance. We assume that the biological variance is the same for treatment
and control. Obviously, we cannot observe Xik for any subject, but must use stereological
methods to “estimate”this quantity.
Let Nˆik be the stereological estimate of Xik. For simplicity, we assume the shape of the
brain region of interest is the same among subjects. In this chapter, we continue to use σst as
the notation for the stereological variance, σst1 and σst2 as the notations of the two parts of
the stereological variance in (2.11), respectively. The within section variance may be based
on either Cruz-Orive and Geiser or Ammeter assumptions. Given Xik, we assume that Nˆik
is approximately normally distributed, and
E[Nˆik|Xik] = Xik,
var[Nˆik|Xik] = σist, i = c or t, (3.3)
where σcst and σ
t
st are the stereological variances of control and treatment groups, respectively.
From the stereological variance formula in Chapter 2, we know that if there is a group
difference the stereological variances are most likely different between groups.
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The unconditional distribution of Nˆik is as follows
E[Nˆik] = E[E[Nˆik|Xik]] = E[Xik] = µi + pk,
var[Nˆik] = var[E[Nˆik|Xik]] + E[var[Nˆik|Xik]] = var[Xik] + E[σist] = σB + σist. (3.4)
Hence,
Nˆik ∼i.i.d N(µi + pk, σB + σist), i = c or t, k = 1, · · · , N, (3.5)
so that the pairwise difference Dk = Nˆck−Nˆtk ∼i.i.d N(µc−µt, 2σB+σcst+σtst), k = 1, · · · , N .
The sample variance of Dk given by s
2
D =
1
N−1
∑N
k=1(Dk−D¯)2 has the following distribution:
(N − 1)s2D ∼ (2σB + σcst + σtst)χ2N−1.
The hypotheses are
H0 : µc = µt,
Ha : µc 6= µt. (3.6)
It is well known that to test H0 based on(3.5), we use the usual paired t-test statistic
T =
¯ˆNc· − ¯ˆNt·√
s2D
N
. (3.7)
Hence, the power function for the 0.05 level test of (3.6) is given by
Power = Pr(reject H0| Ha)
= Pr
| T | > t0.975,N−1| ξ = δ√
2
N
(σB +
σcst+σ
t
st
2
)
 , (3.8)
where the test statistic T follows a noncentral t distribution with N − 1 degrees of free-
dom, and noncentrality parameter ξ, and where t0.975,N−1 is the 0.025 critical value of the t
distribution with N − 1 degrees of freedom, and δ is the pre-specified alternative.
Under the null hypothesis µc = µt, so that the stereological variances are the same
for control and treatment group, that is, σcst = σ
t
st. But under the alternative hypothesis
µc 6= µt, the stereological variances are different for control and treatment group according to
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the stereological variance formula (2.11). P-values are obtained based on the null hypothesis
being true; thus, the paired t test gives the correct p-values. Statistical power is based on
the alternative hypothesis, so the test statistic needs to account for the unequal variances.
However, for the paired study, no matter whether the variances are equal or not between
groups, the paired t statistic is appropriate to use, since the difference statistic depends on
the sum of stereological variance of two groups.
3.1.2 Stereological Variance and Number of Counting Frames
In this section, we present the mathematical relationship between number of counting frames
and stereological variance. Consider two stereological designs on the same region of interest
with length L, where one has K and the other has K∗ counting frames, respectively. We
suppose the number of the sections respectively m and m∗ to be the same between the
two designs. The sizes of the square counting frames are the same among the sections and
between designs, so that af = a
∗
f . The height is also the same within and between designs, so
that h = h∗. The difference between these two stereological designs is that they use different
lengths of grids, where au 6= a∗u and av 6= a∗v. The grid lengths are the same among sections
in the same design. This difference in grid lengths allows us to vary the number of sampling
frames.
Thus, the section sampling fraction and the height sampling fraction are the same for
these two designs:
τs = τ
∗
s ,
τh = τ
∗
h . (3.9)
Let the ratio of two numbers of counting frames be p, i.e., p = K
K∗ , and nj = pn
∗
j for
j = 1, · · · ,m. Since the area of the jth section, Areaj = njauav, is fixed, then
auav = Areaj/nj
= Areaj/(p · n∗j)
=
1
p
· a∗ua∗v. (3.10)
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Hence,
τa = a
2
f/(auav) = a
2
f/(
1
p
· a∗ua∗v) = p · τ ∗a . (3.11)
Recall that in the stereological variance formula in (2.11) (σst = var[N˜ ] + ( Lm)2
∑m
j=1
var[fˆ(X1 + (j − 1) Lm , U1j, V1j)|X1]), the first term on the right hand side is the between
section variation (σst1 = var[N˜ ]). Hence,
N˜ = L
m
m∑
j=1
f(Xj)
=
L
m∗
m∗∑
j=1
f(Xj)
= N˜ ∗, (3.12)
where f(Xj) is the true number of neurons at Xj for j = 1, · · · ,m, so that the between
section variances are the same for two designs when the two designs have the same number
of sections, that is, σst1 = var[N˜ ] = var[N˜ ∗] = σ∗st1.
The between section variance only depends on region length L, section number m and the
f(Xj)’s. It is important to understand that the values of L, m and f(Xj)’s are unchanged
under these two stereological designs, and thus the between section variance component will
be the same no matter how many counting frames are sampled.
The second component of the stereological variance in (2.11) is σst2 = (
L
m
)2
∑m
j=1 var[fˆ(X1+
j L
m
, U1j, V1j)|X1].
Under the Cruz-Orive and Geiser assumption, we have
σst2 = (
L
m
)2
m∑
j=1
1
τ 2ah
2
njλj
= (
L
m∗
)2
m∗∑
j=1
1
(pτ ∗a )2h∗2
pn∗jλj
=
1
p
(
L
m∗
)2
m∗∑
j=1
1
τ ∗2a h∗2
n∗jλj
=
1
p
σ∗st2. (3.13)
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Similarly, assuming we were to use our Ammeter model, we would have
σst2 = (
L
m
)2
m∑
j=1
1
τ 2ah
2
njµAj(1 +
µAj
φAj
)
= (
L
m∗
)2
m∗∑
j=1
1
(pτ ∗a )2h∗2
pn∗jµAj(1 +
µAj
φAj
)
=
1
p
(
L
m∗
)2
m∗∑
j=1
1
τ ∗2a h∗2
n∗jµAj(1 +
µAj
φAj
)
=
1
p
σ∗st2. (3.14)
Hence, for both the approaches the second component of the stereological variance (σst2)
is inversely proportional to the number of counting frames.
In order to obtain our cost considerations, we make a number of simplifying assumptions.
We assume that the shape and the length of brain region of interest are the same for all the
subjects. In the stereological study, we also assume the same number of sections will be
selected for all subjects. In practice, the size and height of the counting frames will be
kept the same through the study. Then the between section variation (σst1) is unchanged
according to the number of counting frames, while the remaining part of the stereological
variance (σst2) and the number of counting frames have an inversely proportional relationship.
The two parts of the stereological variance are assumed to be the same within each group,
but not necessary to be the same between groups.
3.1.3 Theoretical Results
In the last section, we obtained the relationship between the number of counting frames and
the stereological variance. The first term on the right hand side of (2.11) is unchanged under
the systematic sampling design when the number of sections is the same. The second term on
the right hand side of (2.11) and the number of counting frames are inversely proportionally
related. In this section, we use the notation σist1,K0 to be the first term, and σ
i
st2,K0
to be the
second term where the number of counting frames is K0 for each subject in both groups the
control and experimental.
When the number of pairs and the number of counting frames are N and K respectively,
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the noncentrality parameter in the power function (3.7) is given by
ξ =
δ√
1
N
(
2σB + (σcst,K + σ
t
st,K)
)
=
δ√
1
N
(
2σB + (σcst1,K0 +
K0σcst2,K0
K
) + (σtst1,K0 +
K0σtst2,K0
K
)
)
=
δ√
1
N
(
2σB + (σcst1,K0 + σ
t
st1,K0
) +
K0(σcst2,K0
+σtst2,K0
)
K
) . (3.15)
Hence the power function in (3.8), viewed as a function of N and K, is
Power(N,K) = P (reject H0| Ha)
= P
|T | > t.975,N−1| ξ = δ√
2
N
(
σB +
σcst1,K0
+σtst1,K0
2
+
K0(σcst2,K0
+σtst2,K0
)
2K
)
 ,
(3.16)
where δ is the pre-specified alternative, and σB, σ
c
st1,K0
, σcst2,K0 , σ
t
st1,K0
, and σtst2,K0 are known
parameters.
Thus the power function and cost function both depend on the number of pairs N and
the number of counting frames K used in the study. Combining these two functions together,
we have
Power(N,K) = P
|T | > t.975,N−1| ξ = δvuut 2
N
 
σB+
σc
st1,K0
+σt
st1,K0
2
+
K0(σ
c
st2,K0
+σt
st2,K0
)
2K
!

Cost(N,K) = C0 + 2C1N + 2C2NK.
In the next section we consider two ways to optimize cost, two types of optimizations:
I. for a certain power, to minimize the cost of study;
II. for a fixed budget, to maximize the power of study.
3.1.3.1 The Type I Optimization For the type I optimization, let Ωβ be the set of all
possible combinations of numbers of pairs and numbers of counting frames satisfying power
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function ≥ 1− β, at the alternative δ, that is
Ωβ = {(N,K) : Power(N,K) ≥ 1− β}. (3.17)
Denote the type I optimal combination as (N,K)opt,I which is the combination minimiz-
ing the cost function Cost(N,K) in Ωβ.
Given δ and β, let σδ,β(N) denote the variance of the pairwise difference in order for
a study of N pairs subjects to reach at least 1 − β power. σδ,β(N) can be obtained from
noncentral t power calculates for a given number of pairs N . When the number of counting
frames for each subject is K, σδ,β(N) in the power function (3.16) can be given in terms of
σB, K0, σ
c
st1,K0
, σtst1,K0 , σ
c
st2,K0
, and σtst2,K0 , that is
σδ,β(N) = 2σB + (σ
c
st1,K0
+ σtst1,K0) +
K0(σ
c
st2,K0
+ σtst2,K0)
K
. (3.18)
Note that σδ,β(N) is a function of N , so that the solution of K is obtained as a function
of N
K(N) =
[
K0(σ
c
st2,K0
+ σtst2,K0)
σδ,β(N)− 2σB − (σcst1,K0 + σtst1,K0)
]
, (3.19)
where [a] is the smallest integer larger than a and K > 0. For a given N , K is adjusted
to change the stereological variance, and hence the variance of the primary outcome (Nˆ ) in
order to achieve the desired power. Thus, among all the possible combinations of (N,K)
that satisfy the statistical power, the optimal combination of (N,K) is given by
(N,K)opt,I = argminΩβCost(N,K(N))
= argminΩβ {C0 + C1N + C2NK(N)}
= argminΩβ {C2(C1/C2N +NK(N))}
= argminΩβ {C1/C2N +NK(N)} , (3.20)
where C0, C1 and C2 are positive constants in the cost function. Note that to find the
optimal combination, it is sufficient to know C1/C2 which is the relative cost of a subject to
the cost of a counting frame.
To illustrate the Type I optimal results one can obtain from the optimization approach,
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Table 3.1: Type I Optimal Combination of Number of Pairs and Number of Counting Frames
(N,K)opt,I .
C1/C2 1− β = 0.70 1− β = 0.75 1− β = 0.80 1− β = 0.85 1− β = 0.90
10 (26, 52) (28, 54) (34, 49) (38, 50) (42, 53)
20 (22, 64) (24, 66) (26, 69) (29, 70) (34, 69)
50 (15, 110) (17, 106) (19, 106) (21, 109) (23, 118)
100 (13, 138) (14, 144) (15, 153) (17, 151) (19, 158)
500 ( 9, 286) ( 9, 395) (10, 350) (11, 361) (13, 329)
1000 ( 8, 391) ( 8, 514) (9, 472) (10, 471) (11, 516)
10000 ( 6,1506) ( 7, 906) ( 7, 1591) (8,1209) (9, 1203)
we consider an example where the results are given in Table 3.1. In this example, the param-
eters used for the optimal calculation are δ = 20, σB = 100, K0 = 1000, σ
c
st1,K0
= 1, σtst1,K0 =
2, σcst2,K0 = 30 and σ
t
st2,K0
= 40 in Table 3.1. The range of power is (0.70, 0.75, 0.80, 0.85, 0.90)
and a relatively large range of relative costs C1/C2 (= 10, 20, 50, 100, 500, 1000, 10000) are
considered. The optimal results in Table 3.1 show that at a fixed level of power as the relative
cost C1/C2 increases, then the optimal number of pairs decreases and more counting frames
are added. When the relative cost is small, the number of pairs is what mostly changes in
order to achieve different levels of powers. When the relative cost is large, the number of
counting frames is mostly adjusted for different powers. Clearly, for any relative cost and
required statistical power, we can provide the optimal design for a stereological study.
Since the number of counting frames K is a function of the number of pairs N , the core
part of the cost function (C1/C2N+NK(N)) can also be considered as a function of N . The
core part of the cost function versus the number of pairs for three different β’s are illustrated
in Figure 3.1, where the relative cost C1/C2 is 100. The diamond, circle and triangle denote
power levels of 0.9, 0.8 and 0.7 respectively. The three dots mark the optimal combination
for each power level. Figure 3.1 shows when the number of pairs is small, the cost of study is
42
large, because a huge amount of counting frames is required for each subject. On the other
hand, too many pairs also increase the cost of study. The optimal cost and optimal number
of pairs both increase as the desired power goes large.
Figure 3.1: The Core Part of Cost Function vs. the Number of Pairs for Power(=
0.9, 0.8, 0.7) and Relative Cost C1/C2 (= 100).
3.1.3.2 The Type II Optimization For the type II optimization, let ΩC be the set
including all possible combinations of group size and numbers of counting frames satisfying
the cost function ≤ C. ΩC can be denoted as
ΩC = {(N,K) : Cost(N,K) ≤ C}. (3.21)
The Type II optimal combination is the (N,K)opt,II which maximizes the power function
Power(N, K) in ΩC .
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For a fixed budget C,
C = Cost(N,K) = C0 + 2C1N + 2C2NK = C0 + 2N(C1 + C2K), (3.22)
so that the group size N can be expressed as a function of the number of counting frames
K, where
N(K) =
C − C0
2(C1 + C2K)
. (3.23)
The stereological variance σst also depends on the number of counting frames, given the
relationship in Section 3.1.2.
Hence, the noncentral parameter ξ can also be given as a function of K,
ξ(K) =
δ√
2
N(K)
(σB +
σcst(K)+σ
t
st(K)
2
)
. (3.24)
Now, the power function can be described as
Power(N,K) = P (|T | > t0.975,ν |ξ)
=
∫ t0.025,ν
−∞
f(t)dt+
∫ ∞
t0.975,ν
f(t)dt, (3.25)
where f(t) = ν
ν/2√
piΓ(ν/2)
e−ξ
2/2
(ν+t2)ν+1
∑∞
j=0
ν+j+1
2
ξj
j!
(
2t2
ν+t2
)j/2
, and ν = N − 1 = C−C0
2(C1+C2K)
− 1.
Since the power function now only depends on K, to maximize the power function, it is
equivalent to solving 
dPower(K)
dK
= 0
d2Power(K)
dK2
< 0.
When we consider the type II optimization, this algorithm requires more information
about the three cost coefficients C0, C1 and C2 than was needed for Type I optimization.
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3.2 EXAMPLE
We consider an example which shows how to extend some of the ideas in Section 3.1 and
how to potentially apply if we were to repeat a study like Dr. Konopaske. In the Konopaske
study, 18 monkeys were matched by their body weights as triads and then within triads
assigned at random into the three treatment groups: haloperidol, olanzapine, and sham
control. Using the CE criterion, about 1600-1800 counting frames were collected from each
animal.
In Konopaske et al. (2007) a two-way ANOVA model (with additive effects of group
and triad) was used for the data set consisting of each monkey’s stereologically estimated
total glial cell number in its parietal lobe, in order to assess the effect of chronic antipsy-
chotic exposure. The contrast of the combined antipsychotic-exposed groups vs the sham
group was used to evaluate the effect of chronic antipsychotic exposure. One-sided testing
of the contrast was done due to the directionality of expected reduction glial number in
antipsychotic-exposed monkeys.
To first explore how the number of counting frames affects the final test statistic and
resulting inference, we systematically deleted different proportions of counting frames within
each animal and analyzed the reduced data set. First, we decreased the number of counting
frames K in the data set by 10%. To roughly keep the systematical sampling characteristic,
we systematically deleted the counting frames. Ten subsets for each animal were generated.
For subset i, the ith counting frame of each section was deleted and then every 10th thereafter
is also deleted, i = 1, · · · , 10. All the ith subsets of each animal are combined together as
a new sample of 18 animals. Therefore, ten such samples are generated. Then the two-way
ANOVA model described in Konopaske et al. (2007) is applied to each sample. The estimate
and statistical inference about the contrast between the combined antipsychotic-exposed and
controls from the sample data sets do not change much comparing to the original data set.
Table 3.2 lists the estimate of the average effect of the two chronic antipsychotic exposure
groups minus that of the sham group, the test statistic and the p-values.
We then proceeded to decrease the number of counting frames by 20% and 30% sequen-
tially. The statistical inference changed little (see Appendix A).
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Table 3.2: Comparing the Original Data Set and 10 Samples with 10% Reduction.
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Sample1 -24.5 12.85 -1.91 0.0427
Sample2 -25.8 13.60 -1.90 0.0436
Sample3 -23.2 12.63 -1.84 0.0479
Sample4 -26.4 12.90 -2.05 0.0339
Sample5 -24.5 13.06 -1.87 0.0453
Sample6 -23.7 12.66 -1.87 0.0454
Sample7 -26.2 12.95 -2.02 0.0355
Sample8 -25.1 13.46 -1.86 0.0460
Sample9 -25.1 12.49 -2.01 0.0364
Sample10 -25.4 13.11 -1.93 0.0410
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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A second approach to exploring this issue used the bootstrap method to resample the
data set. To obtain a bootstrap sample with 100p% counting frames of the original data
of each animal using section as a strata variable, p · nj counting frames are independently
selected within the jth sections with replacement, for j = 1, · · · ,m. For each animal, we
obtained a bootstrap sampling with p · K counting frames. We combined the bootstrap
sampling from each animal to get a new sample of 18 monkeys, and performed the two-way
ANOVA analyses. The results of this method are consistent with these obtained from the
preceding systematic deletion (see Appendix B).
Both systematic reduction and bootstrap methods demonstrate that reducing the number
of counting frames will only cause a slight loss of power. Moreover, in an actual study the lost
power could by compensated for by increasing slightly the number of animals. Decreasing
the number of counting frames by 30% in the Konopaske study means reducing 500 counting
frames for each animal, which in turn translates into a reduction of more than a month of
lab work in this study. We will later show in this chapter using the Konopaske data how we
would provide an optimal design which also maintains the original data set’s power.
3.2.1 Paired Design
In Konopaske study, we can estimate the stereological variance from the data set. If someone
wants to repeat the study, we could provide the optimal design based on the information
obtained from the Konopaske’s study. For simplicity, suppose that we only have two groups
matched as pairs in the new study, for example, haloperidol and sham groups. Due to the
directionality of the treatment effect, a one-sided test is considered.
The hypotheses are
H0 : µH = µS,
Ha : µH < µS. (3.26)
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The test statistic in (3.7) is
T =
¯ˆNH· − ¯ˆNS·√
1
N
( 1
N−1
∑N
k=1((NˆH,k − NˆS,k)− ( ¯ˆNH· − ¯ˆNS·))2)
, (3.27)
and the power function for the one-sided test is
Power = P (reject H0|Ha)
= P (T < t.05,N−1| ξ = δ√
1
N
(2σB + σHst + σ
S
st)
), (3.28)
where Nˆi,k is the stereological estimate of the total glial number in the parietal lobe for the
monkey of pair k in group i,
¯ˆNi· is the mean of the stereological estimate of group i, σist is
the stereological variance of group i, i = H (haloperidol) or i = S (sham), and σB is the
biological variance, and δ is the numerical difference in total number that is to be detected.
In the data set, the average numbers of total counting frames used in haloperidol and
sham groups are 1676 and 1646 respectively. We have estimated the two components of
stereological variance for each group by averaging the two components of stereological vari-
ances of subjects within group, respectively. The estimates of σHst1 and σ
S
st1 are 1.5 and 1.5,
respectively, and the estimates of σHst2 and σ
S
st2 are 29.0 and 39.6 (under the Cruz-Orive and
Geiser assumption), respectively, where
σ̂Hst1 =
2.4 + 0.1 + 1.3 + 3.9 + 0.6 + 0.4
6
= 1.5
σ̂Hst2 =
23.3 + 28.0 + 26.4 + 36.2 + 25.8 + 34.3
6
= 29.0
σ̂Sst1 =
1.7 + 0.5 + 2.0 + 0.2 + 3.1 + 1.4
6
= 1.5
σ̂Sst2 =
41.7 + 32.1 + 50.4 + 23.8 + 49.8 + 39.7
6
= 39.6,
and the numbers can be obtained in Table 2.3.
48
The estimated noncentrality parameter for N pairs and K counting frames is
ξˆ =
δ√
1
N
(2σB + (σˆHst1 +
1676
K
σˆHst2) + (σˆ
S
st1 +
1646
K
σˆSst2))
=
δ√
1
N
(2σB + (1.7 + 29.2
1676
K
) + (1.4 + 38.81646
K
))
=
δ√
1
N
(2σB + 3.1 +
112804
K
)
. (3.29)
Based on the information obtained from the data set, we are able to decide the number
of counting frames and sample size for a new study. The following table lists the numerical
results for different pre-specified alternatives and relative costs of a study with 80% power.
Table 3.3: Optimal Combination (N,K)opt,I for Konopaske Study - Paired Case.
δ σB C1/C2 N K
-20 202 100 29 116
1000 19 342
10000 16 821
-30 202 100 14 112
1000 9 398
10000 8 828
-20 152 100 20 153
1000 12 500
10000 10 1176
-30 152 100 11 123
1000 7 338
10000 6 610
In Konopaske data, the observed difference for haloperidol and sham group is -31.8 and
the observed biological variance is 760.4. The optimal combination for the study is (12, 574)
when the relative cost is 10000.
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3.2.2 Matched Triads
In this section, we consider the issue involving in repeating the Konopaske’s study exactly.
Due to the assumption of unequal stereological variance among groups under the alternative
hypothesis, the triad case is more complex than the paired case. We use Sattherwaite’s
approximation to adjust the test statistic.
The hypothesis of interest here is
H0 :
µH + µO
2
= µS
Ha :
µH + µO
2
< µS. (3.30)
Let σ denote var[
¯ˆ
NH·+
¯ˆ
NO·
2
− ¯ˆNS·], so that
σ =
1
4
var[
¯ˆ
NH·] +
1
4
var[
¯ˆ
NO·] + var[
¯ˆ
NS·]
=
1
4
(σB + σ
H
st ) +
1
4
(σB + σ
O
st) + (σB + σ
S
st)
=
3
2N
σB +
1
4N
σHst +
1
4N
σOst +
1
N
σSst. (3.31)
Let MSi =
1
N−1
∑N
k=1(Nˆik − ¯ˆNi·)2, then (N − 1)MSi ∼ var[ ¯ˆNi·]χ2N−1, i = H,O and S.
Using the Satterthwaite approximation, we have
v̂ar[
¯ˆ
NH· +
¯ˆ
NO·
2
− ¯ˆNS·] = 1
4N
MSH +
1
4N
MSO +
1
N
MSS, (3.32)
so that v̂ar[
¯ˆ
NH·+
¯ˆ
NO·
2
− ¯ˆNS·]/σ can be approximated as a χ2 distribution with degrees of
freedom given by
df =
( 1
4N
MSH +
1
4N
MSO +
1
N
MSS)
2
( 1
4N
MSH)2+(
1
4N
MSO)2+(
1
N
MSS)2
N−1
=
(1
4
MSH +
1
4
MSO +MSS)
2
( 1
4
MSH)2+(
1
4
MSO)2+MSS)2
N−1
. (3.33)
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A suitable test statistic of hypothesis (3.30) would be
T =
¯ˆNH·+ ¯ˆNO·
2
− ¯ˆNS·√
v̂ar[
¯ˆNH·+ ¯ˆNO·
2
− ¯ˆNS·]
. (3.34)
The resulting power function is
Power(N,K) = P (reject H0|Ha)
= P (T < t.05,df | ξˆ), (3.35)
where given the alternative δ, T has a noncentral t distribution with a df given in (3.33) and
the estimated noncentral parameter being
ξˆ =
δ√
1
N
(3σB +
1
4
(σˆHst1 +
K0
K
σˆHst2) +
1
4
(σˆOst1 +
K0
K
σˆOst2) + (σˆ
S
st1 +
K0
K
σˆSst2)
. (3.36)
The optimal algorithm is similar as the paired case, where we need the two components
of stereological variances of the three groups. Optimal results for the triads case can be
obtained as Table 3.3.
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4.0 ADAPTIVE DESIGN
4.1 INTRODUCTION
Chapter 3 shows that to plan an optimal design we need the information about the sizes of
the biological and stereological variances, which are unknown prior to study. Traditionally,
researchers estimate such values from previous experience for the experimental design. We
know from Chapter 2 that the stereological variance depends on the shape of the region of
interest and on the number of neurons in it. Hence, it is difficult to prespecify the stereological
variance before a study that is interested in a particular type of neuron. When the design
parameters are incorrectly prespecified in the optimality calculation, the number of subjects
and the number of counting frames may be incorrect. To avoid inefficient use of resources
in stereological studies, we propose to introduce ideas from adaptive designs that have been
widely studied and implemented in clinical trials during the past decade. An adaptive design
allows us the opportunity to look at the data at an interim stage, and to modify the design
based on the information obtained from the first stage data. The flexibility of adaptive design
allows adjusting the sample size and the number of counting frames when the variability is
mis-specified. Adaptive procedures can have cost advantages over standard fixed procedures.
In this chapter we apply two stage adaptive procedures in stereology. While in the literature
both blinded and unblinded procedures have been considered, we focus on blinded adaptive
design procedures.
Several different unblinded adaptive procedures are described by Proschan and Huns-
berger (1995), Shun (2001), Liu and Chi (2001). These designs unblind the treatment as-
signments at the end of Stage I, so that the group means and common variance can be
estimated and used in the design of Stage II.
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Blinded adaptive procedures (e.g., Stein (1945), Gould and Shih (1991), Gould and Shih
(1998), Kieser and Friede (2001)) do not break the blind at the end of Stage I. Typically
for these designs, only the common within-group variance is attempted to be estimated, and
usually the sample size of Stage II is re-estimated based on the estimate of the variance.
In our adaptive procedure, we only estimate the stereological variance without breaking
the blind of the Stage I data. Our goal is to design Stage II with the information obtained
from Stage I. At the end of Stage I, we estimate the stereological variance, and adjust the
number of counting frames in Stage II. We develop the appropriate test procedure and show
that the type I error rate is controlled.
4.2 ADAPTIVE PROCEDURE
In the current chapter, we develop a blinded adaptive procedure in which the diagnostic codes
for the subjects remain blinded until the end of the stereological study. Unlike traditional
blinded procedure, we only estimate the stereological variance based on the blinded Stage
I data instead of the variance of the primary outcome (number of neurons), which involves
both biological variance and stereological variance components. Particularly, we consider
the situation in which the design of Stage II, such as the number of counting frames for
each subject and/or the sample size, depends on Stage I observations. In our procedure,
we always assume that the biological variance is known and kept the same between stages.
However, adjusting the number of counting frames in Stage II creates the difficulty that the
variances at the subject level will be different between two stages . The usual paired t test
is not appropriate for our procedure, and we propose to use an adjusted t-statistic.
The motivation for developing a two-stage adaptive procedure for the stereological study
is due to the fact that it is difficult to prespecify the design parameters concerning the
stereological variances prior to the beginning of the study which focuses on a particular type
of neurons. The stereological variances can vary from study to study, since the stereological
variation depends on the number of counting frames, and adjusting the number of counting
frames changes the stereological variation.
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A stereological study based on our adaptive design gives us the opportunity to look at
the blinded data without revealing the treatment and pair assignments at the end of Stage
I. The design of Stage II depends on the updated information concerning the stereological
variance. We find that our two-stage adaptive procedure presents an advantage in terms of
efficient use of resource with claimed power. One of the challenges for our statistical method
is to maintain appropriate control of Type I error rate while permitting adaptation.
4.3 ADJUSTING THE NUMBER OF COUNTING FRAMES (K2) OF
STAGE II
4.3.1 Introduction
In this section, we consider only adjusting the number of counting frames for Stage II, while
keeping the sample size of a study fixed. In fact, the total number of subjects that are
available to be used in a study is often fixed by the budget or the available resources for
many studies. For example, Dr. Konopaske’s study had a fixed number of monkeys that
were available. However, the number of counting frames can be adjusted to assure improved
power for detecting a treatment effect under a proposed alternative. Under the uniformly
→ →
Figure 4.1: Uniformly Systematic Sampling Scheme
systematic sampling scheme of a stereological study (Figure 4.1), the section sampling step
and the height sampling step remain unchanged for the two stages of the adaptive design,
and only the area sampling step is adjusted to adjust the number of counting frames. The
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way to adjust the number of counting frames is by altering the distances between the crossing
lines which are called u-step (au) and v-step (av) of the grid. The other characteristics of
the stereological design, such as the number of sections, the area of a counting frame and
the thickness of a counting frame in a stereological study, are kept the same though the
entire study. An advantage of keeping a fixed number of sections across stages is that the
researchers can prepare the section slices in advance and don’t need to wait until Stage I is
finished. Figure 4.2 given by (Schmitz and Hof (2007)) illustrates a series of selected sections
of brain tissues.
Figure 4.2: Section samplings (Schmitz and Hof (2007))
Let us suppose that the study is interested in a brain region with length L. The region
is cut into M sections and m sections will be systematically chosen for examination. The
thickness and the area of the counting frame are h and a2f , respectively. The areas of
each section selected are denoted by (Area1, ...., Aream), respectively. The section sampling
fraction (τs) and height sampling fraction (τh) are given by
τs =
m
M
τh =
h
L/M
.
In an actual stereological study, the researchers choose the u-step (au) and v-step (av) in
order to obtain the required number of counting frames. They can decrease the number of
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counting frames by enlarging the distances between the cross lines and making the rectangle
larger, so that fewer number of counting frame are observed, and to increase the number of
counting frames they decrease the relevant distances. The area sampling fraction is given by
τa =
a2f
auav
,
and the corresponding numbers of counting frames in each section are
nj =
Areaj
auav
, j = 1, · · · ,m. (4.1)
Hence
nj
τa
=
Areaj
a2f
, j = 1, · · · ,m. (4.2)
Area1, · · · , Aream, and a2f are fixed and known for a study; thus, the number of counting
frames K =
∑m
j=1 nj and the sampling fraction τa have a proportional relationship.
Following the simple Cruz-Orive and Geiser approach, we assume that the number of
neurons counted in each counting frame follows a Poisson distribution with the same λ among
sections (see Section 2.3). Based on the Poisson assumption, the measurement function given
by (2.4) on each section is fj =
1
τah
njλ =
λ
a2fh
Areaj, j = 1, ...,m. Then the two components
of the stereological variance are given by
σst1 =
L2
240m2
(3
m∑
j=1
f 2j +
m−2∑
j=1
fjfj+2 − 4
m−1∑
j=1
fjfj+1)
=
L2λ2
240m2h2a4f
(3
m∑
j=1
Area2j +
m−2∑
j=1
AreajAreaj+2 − 4
m−1∑
j=1
AreajAreaj+1), (4.3)
and
σst2 =
1
τ 2s τ
2
a τ
2
h
λ
m∑
j=1
nj
=
[
L2λ
m2h2a4f
m∑
j=1
Areaj
]
auav. (4.4)
As previously noted, for a stereological study, L, m, h, af and Areaj, j = 1, · · · ,m are
known and fixed. Thus, the first component (4.3) of the stereological variance is fixed for a
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study, and the second component (4.4) of the stereological variance depends on the distance
between the cross lines of the grid (au and av). The number of counting frames is determined
by au and av.
In designing a stereological study one choses au and av based on pre-specified design
parameters: type I error rate α, type II error rate β, total pairs of subject N , biological
variance σB, alternative δ, and λ0, where λ0 is the initial guess of the true parameter λ.
These will determined the number of counting frames, K1, in the Stage I. The details for
this calculation are discussed in Section 4.3.2. Let K2 denote the number of counting frames
re-calculated for Stage II. The procedure of choosing K2 will be discussed in Section 4.3.3.
4.3.2 Planning Stage
In a matched pair study, the numbers of control and treatment subjects are balanced within
each stage. In fact, the tissue specimens are often processed in batches and that pairs always
appear in the same batch (to protect against batch to batch variation). We assume that
the region of interest is basically the same among subjects for both treatment and control
groups. We also assume that the stereological design parameters, such that the section
sampling fraction, the area sampling fraction and the height sampling fraction, are the same
for both stages. Hence, the same number of counting frames for each subject are collected
within each stage.
In a study designed for CCNMD, control and treated subjects are pair-matched by co-
variates, such as age at death, gender, post-mortem interval and brain pH value. Let Nˆi,γ
be the stereological estimate of the neuron number of pair γ from i = control or treatment
groups, respectively. Then
Nˆi,γ ∼i.i.d N(µc + pγ, σB + σist), (4.5)
where µi is the mean of group i (i = c or i = t), pγ is the effect of pair γ satisfying∑N
γ=1 pγ = 0 and σB is the biological variance. We assume that the biological variance is the
same for treatment and control groups, but the stereological variances may be different due
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to the differing neuron numbers for treatment and control. The hypotheses that one test are
H0 : µc = µt
Ha : µc 6= µt. (4.6)
To design a stereological study with a fixed number of pairs, the number of counting
frames needs to be decided. It is important to note that the difference statistic only depends
on the average of the stereological variances of treatment and controls for the paired studies
(see Section 3.1.1). An initial guess of the average intensity of the Poisson distribution of
treatment and control is λ0. A simple paired t test is used to determine au and av. The
power function for a two-sided α level test of (4.6) can be expressed by
Power = P (reject H0| Ha)
= P
| T | > t1−α/2,N−1| ncp = δ√
1
N
((σB + σcst1 + σ
c
st2) + (σB + σ
t
st1 + σ
t
st2))

= P
| T | > t1−α/2,N−1| ncp = δ√
2
N
(σB + σ¯st1 + σ¯st2)
 , (4.7)
where α denotes the nominal type I error rate, 1− β denotes the planned power, t1−α/2,N−1
denotes the 1 − α/2 critical value of the t distribution with N − 1 degrees of freedom, δ
is the pre-specified alternative, σB is the biological variance, ncp the corresponding non-
centrality parameter of the noncentral t-distribution for T , and σ¯st1 (= (σ
c
st1 + σ
t
st1)/2) and
σ¯st2 (= (σ
c
st2 + σ
t
st2)/2)are the average of the two components of the stereological variances
(i.e., (4.3) and (4.4)) for treatment and control groups, respectively. Substituting (4.3) and
(4.4) for the two components of the stereological variance in the power function (4.7), we
have that the resulting equations directly, relates power to auav with all parameter values
fixed by design, so that by a suitable choice of auav, we can obtain the desired power.
Note, there can be situations when σB is too large, so that power is unachievable. For a
fixed N pairs subjects, to detect a difference of δ, ξ{δ,β,N} which is the effect size to achieve
1−β power is also fixed. If the biological variance is relative large compared to the alternative
δ, such that δ/
√
2σB ≤ ξ{δ,β,N}, the study power can’t be obtained by adjusting the number
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of counting frames, even with a very large number of counting frames. Also, when the
average of the first component of the stereological variance σ¯st1 is too large, the study power
can be unachievable.
Now, we give a simple hypothetical example to demonstrate how to select the u-step
(au) and v-step (av) of grid for a stereological study. Table 4.1 gives an example of a set of
Table 4.1: An Example
N σB δ L(mm) a
2
f (µm
2) h(µm) m λ0
20 400 20 25 512 30 10 0.636
Note: The units for σB and δ are 1012and106, respectively.
parameters for a stereological study. The length of the region of interest is 25 mm and 10
sections will be used in the study. The areas of the 10 sections are 204.8 mm2, 230.4 mm2,
256.0 mm2, 281.6 mm2, 307.2 mm2, 307.2 mm2, 281.6 mm2, 256.0 mm2, 230.4 mm2 and
204.8 mm2, respectively. The area and the thickness of a counting frame are 512 µm2 and
30 µm, respectively.
With the initial guess of the average intensity of the Poisson distribution being 0.636,
the average of the first components of the stereological variance is
σ¯st1 =
L2λ20
240m2h2a4f
(3
m∑
j=1
Area2j +
m−2∑
j=1
AreajAreaj+2 − 4
m−1∑
j=1
AreajAreaj+1)
=
(25 ∗ 103)2 ∗ 0.6362
240 ∗ 102 ∗ 302 ∗ 5122 (3 ∗ 668467.2 ∗ 10
12 + 564920.3 ∗ 1012 − 4 ∗ 623902.7 ∗ 1012)
= 3.3 ∗ 1012.
And the average of the second component of the stereological variance is
σ¯st2 = [
L2λ0
m2h2a4f
m∑
j=1
Areaj]auav
=
(25 ∗ 103)2 ∗ 0.636
102 ∗ 302 ∗ 5122 ∗ 2560 ∗ 10
6auav
= 43131510auav.
In this example, the total number of pairs N and the biological variance σB are assumed
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to be 20 and 400 ∗ 1012, respectively. To detect a difference of δ for a study with N pairs
subjects, ξ{δ,β,N} is the effect size to achieve 1 − β power. ξ{δ,β,N} can be obtained from
noncentral t power calculates. and is 0.66 in our case. Accordingly the effect size is related
to auav by
ξ{20,0.2,20} =
δ√
2(σB + σ¯st1 + σ¯st2))
=
20√
2(400 + 3.3 + 43131510auav ∗ 10−12)
.
Usually, we use the same u-step (au) and v-step (av), so that
au = av =
√√√√(( 20
.66
)2
/2− 400− 3.3
)
/(43131510 ∗ 10−12)
= 1.131 mm.
When the u-step and v-step is 1.131 mm, then the number of counting frames to be
collected is
K1 =
∑m
j=1 Areaj
auab
=
2560
1.131 ∗ 1.131
= 2000.
Thus, we use the u-step and v-step being 1.131 mm and have 2000 counting frames in
this study. This example will also be used in the simulation study in Section 4.3.6.
Note that in the planning stage, we use the average intensity of treatment and control in
the calculation for simplicity. In fact, for the second component of the stereological variance
σst2,
σ¯st2 =
σcst2 + σ
t
st2
2
= (
L2λc
m2h2a4f
m∑
j=1
Areajauav +
L2λt
m2h2a4f
m∑
j=1
Areajauav)/2
=
L2λ0
m2h2a4f
m∑
j=1
Areajauav,
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where λc and λt is the intensity for control and treatment group, respectively. And the
average intensity λ0 = (λc+λt)/2. But the average of the first component of the stereological
variance,
σ¯st1 =
σcst1 + σ
t
st1
2
=
L2
240m2h2a4f
(3
m∑
j=1
Area2j +
m−2∑
j=1
AreajAreaj+2 − 4
m−1∑
j=1
AreajAreaj+1)(λ
2
c + λ
2
t )/2,
which requires the specification of both λc and λt. However, σst1 is usually small compare
with the σst2. In the previous example, σst1 and σst2 are 3.3∗1012 and 55.8∗1012, respectively.
4.3.3 Details of the Blinded Adaptation
The two components of the stereological variance in (4.7) are never known exactly in practice,
and so in planning a study can only be guessed from previous experiments. Clearly, the
number of counting frames will be either too large or too small when an initial choice of
stereological variance is mis-specified. It is wasteful of time and money using more counting
frames than necessary, and using an inadequate number of counting frames will increase the
likelihood of an inconclusive study, which also wastes time and money.
Countering the uncertainty of the initial guess of stereological variance motives us to
apply adaptive procedures to stereological studies. After obtaining first N1 pairs subjects,
the data are kept blinded and the two components of the stereological variance are estimated
using interim observations. Unlike some blinded sample size re-estimation procedures used
in clinical trials, such as Gould and Shih (1992), the biological variance is not re-estimated
in our procedure. At the end of Stage I, we don’t have any information about the treatment
and pair assignments. Only the counted number of neurons in each of the K1 counting
frames is available for each subject. However, this information is sufficient for us to estimate
the stereological variance, because the variance of pairwise difference depends on the average
of treatment and controls stereological variance components , and the average stereological
variance components can be estimated from the paired Stage I data without breaking the
blind. Our goal in using blinded data is to avoid paying the typical penalties caused by
breaking the blind. As in clinical trials, procedures for estimating variability based on
61
blinded data before the completion of the study tend to be more scientifically acceptable.
Also, in the clinical trials literature, a number of authors have found that the inflation of
type I error rate is at most slight when modifying designs using blinded data. We employ
blinded estimation of the stereological variance to adjust the number of counting frames in
Stage II, if necessary, to provide the required power against the null hypothesis when the
alternative hypothesis is true.
4.3.4 Two Stage Data Structures
Before we present the strategy for picking the number of counting frames for Stage II, we
give the structure of the two stage data. Note that the stereological variances in the two
stages are different wherever the number of counting frames changes in Stage II. At this
point to establish the appropriate notation, we are assuming that K2 doesn’t depend on the
first stage data. Also assumed is that the distribution of the stereological estimates follows
a normal distribution. N1 and N2 denote the numbers of pairs in two stages, respectively,
and N = N1 +N2. N , N1 and N2 are all fixed in our procedure. Let Nˆ ζi,γ be the stereological
estimates of neuron number for control or treatment subjects (i = c or t), in the ζth Stage,
ζ = 1, 2, for the γth pair, γ = 1, · · · , Nζ , where
Nˆ ζi,γ ∼ N(µi + pζ,γ, σB + σist,Kζ), (4.8)
Then the pairwise differences between treatment and control subject within a pair in each
of the two stages are
Dζγ = Nˆ ζc,γ − Nˆ ζt,γ ∼ N(µc − µt, 2σB + σcst,Kζ + σtst,Kζ), γ = 1, · · · , Nζ , ζ = 1, 2, (4.9)
and their average
D¯ζ =
1
Nζ
Nζ∑
γ=1
Dζγ ∼ N
(
µc − µt, (2σB + σcst,Kζ + σtst,Kζ)/Nζ
)
, ζ = 1, 2. (4.10)
where Kζ denotes the number of counting frames used in Stage ζ, ζ = 1, 2.
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The difference between treatment and control at the end of study is
D¯ =
¯ˆNc − ¯ˆNt = 1
N
[(N1
¯ˆN 1c +N2 ¯ˆN 2c )− ( ¯N1Nˆ 1t +N2 ¯ˆN 2t )]
=
N1
N
(
¯ˆN 1c − ¯ˆN 1t ) +
N2
N
(
¯ˆN 2c − ¯ˆN 2t )
=
N1
N
D¯1 +
N2
N
D¯2, (4.11)
so that
var[D¯] =
N1
N2
(2σB + σ
c
st,K1
+ σtst,K1) +
N2
N2
(2σB + σ
c
st,K2
+ σtst,K2). (4.12)
Hence,
D¯ ∼ N(µc − µt, N1
N2
(2σB + σ
c
st,K1
+ σtst,K1) +
N2
N2
(2σB + σ
c
st,K2
+ σtst,K2)). (4.13)
If K1 = K2, then D¯ ∼ N(µc−µt, 1N (2σB+σcst,K1+σtst,K1)), which has the same distribution
as the simple paired case.
In the next section we show how to choose K2, but now we are proposing the test statistic
which will be used after the completion of the study. Since the variances in the two stages
are different, the simple paired t-test which is the basis for the power calculation in (4.7) is
not appropriate. The distribution given in (4.13) suggests to consider a linear combination
of sample variances in the two stages to estimate the variance of D¯.
The sample variances of difference in each of the two stages are
s2Dζ =
1
Nζ − 1
Nζ∑
γ=1
(Dζγ − D¯ζ)2, (4.14)
where
Nζ−1
2σB+σ
c
st,Kζ
+σtst,Kζ
s2Dζ ∼ χ2Nζ−1, for ζ = 1, 2.
Then E[s2Dζ ] = 2σB + σ
c
st,Kζ
+ σtst,Kζ and V ar[s
2
Dζ
] =
2(2σB+σ
c
st,Kζ
+σtst,Kζ
)2
Nζ−1 follow from the
moments of the χ2 distribution.
Now let
s2 =
N1
N2
s2D1 +
N2
N2
s2D2 , (4.15)
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then
E[s2] =
N1
N2
E[s2D1 ] +
N2
N2
E[s2D2 ]
=
N1
N2
(2σB + σ
c
st,K1
+ σtst,K1) +
N2
N2
(2σB + σ
c
st,K2
+ σtst,K2). (4.16)
Thus s2 is an unbiased estimate of the variance of D¯.
Then we have
V ar[s2] =
(
N1
N2
)2
V ar[s2D1 ] +
(
N2
N2
)2
V ar[s2D2 ]
=
(
N1
N2
)2 2(2σB + σcst,K1 + σtst,K1)2
N1 − 1 +
(
N2
N2
)2 2(2σB + σcst,K2 + σtst,K2)2
N2 − 1 . (4.17)
So s2 can be used as the denominator of an approximate t-statistic. We want to find the
degree of freedom df such that df ·s
2
E[s2]
has approximately χ2df distribution. The Satterthwaite
is one such approximation, and attempts to choose df such that the variance of df ·s
2
E[s2]
matches
that of the χ2df distribution where
V ar
[
df · s2
E[s2]
]
=
df 2 · V ar[s2]
E2[s2]
= 2 · df. (4.18)
Note that by definition, the mean of df ·s
2
E[s2]
already matches that of the χ2df distribution.
Then
df =
2 · E2[s2]
V ar[s2]
=
[
N1
N2
(2σB + σ
c
st,K1
+ σtst,K1) +
N2
N2
(2σB + σ
c
st,K2
+ σtst,K2)
]2(
N1
N2
)2 (2σB+σcst,K1+σtst,K1 )2
N1−1 +
(
N2
N2
)2 (2σB+σcst,K2+σtst,K2 )2
N2−1
. (4.19)
Thus, the test statistic
T =
D¯√
s2
(4.20)
has approximately a tdf distribution with df defined by (4.19).
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When K1 = K2, the degrees of freedom df is
df =
[
N1
N2
(2σB + σ
c
st,K1
+ σtst,K1) +
N2
N2
(2σB + σ
c
st,K1
+ σtst,K1)
]2(
N1
N2
)2 (2σB+σcst,K1+σtst,K1 )2
N1−1 +
(
N2
N2
)2 (2σB+σcst,K1+σtst,K1 )2
N2−1
=
(
N1
N2
+ N2
N2
)2(
N1
N2
)2 1
N1−1 +
(
N2
N2
)2 1
N2−1
=
N2
N21
N1−1 +
N22
N2−1
.
Hence when N1 = N , df = N − 1 which is the same as simple paired study. When
N1 = 0.5N , df = N − 2 which is 1 degree of freedom less than the paired one, which is the
cost for carrying out a two stage procedure.
For the moment ignoring the adaptation, we are able to assume s2D1 and s
2
D2
are inde-
pendent random variables. When performing an unblinded adaptive design, the concern is
doing the analysis at the end of the study ignoring the adaptation might inflate the type I
error rate. Nonetheless, even after K2 is chosen adaptively based on blinded Stage I data we
propose in Section 4.3.5, to use the t-test in (4.20) to test whether or not the treatment and
control population neuron counts differ. However, in related settings with blinded sample
size adjustments, other researchers have found no inflation of the type I error in an approach
like ours. For example, Gould and Shih (1991) described an approach to recalculating sample
size that allowed estimating the variance without unblinding the data at the end of the first
stage, and the approach protected type I error rate. The type I error rate for our procedure
is discussed in Section 4.3.6.1.
4.3.5 Choice of K2
In this section we show how to choose the number of counting frames K2 for Stage II. We
note that the power function for the t-statistic in (4.20) assuming K2 is not a function of
Stage I is
1− β = Power = P (|T | > t0.975,df |ncp). (4.21)
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Under the alternative δ, the non-centrality parameter is
ncp =
δ√
N1
N2
(2σB + σcst,K1 + σ
t
st,K1
) + N2
N2
(2σB + σcst,K2 + σ
t
st,K2
)
, (4.22)
and the degrees of freedom is defined by (4.19).
Our adaptive approach uses the stereological variance estimators based on Stage I and
combines the two stages data using the t-test of (4.20), ignoring the fact that we have done
an adaptation. The stereological design for Stage II is adjusted according to the Stage I
estimates. In particularly, the estimated stereological variance at the end of Stage I will be
used in determining the number of counting frames of Stage II. Our approach is to adjust the
number of counting frames for Stage II by updating the stereological variance components
in the power function (4.7). The power function with this estimation is now given by
1− β = P (|T | > t1−α/2, bdf(K2)|n̂cp(K2)), (4.23)
where
n̂cp(K2) =δ/{N1
N2
[2σB + (σ̂
c
st1,K1
+ σ̂tst1,K1) + (σ̂
c
st2,K1
+ σ̂tst2,K1)]+
N2
N2
[2σB + (σ̂
c
st1,K1
+ σ̂tst1,K1) +
K1
K2
(σ̂cst2,K1 + σ̂
t
st2,K1
)]}− 12 , (4.24)
and estimated degrees of freedom
d̂f(K2) ={N1
N2
[2σB + (σ̂
c
st1,K1
+ σ̂tst1,K1) + (σ̂
c
st2,K1
+ σ̂tst2,K1)]
+
N2
N2
[2σB + (σ̂
c
st1,K1
+ σ̂tst1,K1) +
K1
K2
(σ̂cst2,K1 + σ̂
t
st2,K1
)]}2
/{
(
N1
N2
)2 [2σB + (σ̂cst1,K1 + σ̂tst1,K1) + (σ̂cst2,K1 + σ̂tst2,K1)]2
N1 − 1
+
(
N2
N2
)2 [2σB + (σ̂cst1,K1 + σ̂tst1,K1) + K1K2 (σ̂cst2,K1 + σ̂tst2,K1)]2
N2 − 1 }. (4.25)
Note that the number of counting frames K1 in Stage I cannot be changed, but that
we can change the number of counting frames K2 in Stage II, based on our estimate of the
average stereological variances from Stage I. Observe that both the non-centrality parameter
(n̂cp(K2)) and degrees of freedom (d̂f(K2)) are functions of K2. For the pre-specified alter-
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native δ and fixed sample size, the power function only depends on the number of counting
frames of Stage II (K2). Our adaptive design for the second stage of the study selects K2 to
satisfy the power equation (4.23). In essence, we are estimating one of the design parame-
ters which we may have mis-specified in the initial study design, and then recomputing the
power taking into account that the number of counting frames in Stage I is already fixed.
Simulation results which are provided in Section 4.3.6 indicate that our approach preserves
the type I error rate well.
In order to obtain K2 counting frames for each subject in Stage II, the u-step and v-step
are adjusted to
√
K1
K2
au and
√
K1
K2
av, respectively. Consider the example in Section 4.3.2, if K2
required in Stage II is 1000, then the u-step and v-step are adjusted to
√
2000/1000∗1.131 =
1.599 mm.
It is important to reiterate that the distribution (4.13) of the difference statistic only
depends on the average of the stereological variances of treatment and controls. Thus, the
two stereological variance components can be estimated by the average of the treatment and
control components from the paired Stage I data which can be done without breaking the
blind. Applying the method described in Chapter 2, the two components of the stereological
variance can be obtained separately for each animal using (2.20) and (2.27). Then the two
components of the stereological variance estimate is given by the average, for υ = 1, 2,
σ̂st,υ,K1 =
¯̂σ
c
st,υ,K1
+ ¯̂σ
t
st,υ,K1
2
=
∑N1
γ=1 σ̂
cγ
st,υ,K1
+
∑N1
γ=1 σ̂
tγ
st,υ,K1
2N1
, (4.26)
where σ̂iγst,υ,K1 is the υ
th component (υ = 1 corresponds to between section variance and
υ = 2 to within section variance) of the stereological variance estimate of the γth pair in the
group i (i = c or i = t), and ¯̂σ
i
st,υ,K1
is the average of the υth component of the stereological
variance estimate of the group i (i = c or i = t). The stereological variance estimates in
(4.26) are the updated stereological variances at the end of Stage I and used for designing
of Stage II. The two components of the stereological variance are used in the power function
(4.23).
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4.3.6 Simulation
To demonstrate that the null hypothesis distribution of the proposed test statistic (4.20) is
appropriately approximated by the corresponding t distribution with df defined in (4.19),
we conduct a simulation study. Our simulation continues the example in Section 4.3.2. The
parameters used in the simulation are listed in Table 4.2. Following Section 4.3.2, for a
fixed sample size stereological study, we pick K1 = 2000 based on our initial guess (λ0 =
0.636) of the average intensity of Poisson distribution under the Cruz-Orive assumption.
The numbers of counting frames in each section are calculated based on (4.1), which are
(160, 180, 200, 220, 240, 240, 220, 200, 180, 160), respectively, in Stage I.
4.3.6.1 Type I error rate In the simulation study, we generate the counting frame data
for each subject. Under the null hypothesis, the population numbers of neurons in the control
and experimental groups are the same and two groups have the same population intensities.
Note that the true stereological variability depends on the true population intensity, λ, of
neurons in each counting frame which as noted under the null is the same for both treatment
and control groups. In this simulation study, we explore the effects of differing λ (= 0.4, 0.5,
0.6, 0.7,0.8) on the type I error rate. For each subject, the numbers of neurons counted in
each counting frame is independently generated according to Poisson(λ).
First, we generate the counting frame data for Stage I with N1 pairs. In the simulation,
we explore the effects of various choices of N1 from 5 = 25%N to 15 = 75%N .
Stage I Simulation In Stage I, for subject l1 in group i , the counted number Q
1,l1,i
jk in k
th
counting frame jth section follows a distribution of Poisson(λ), where i = c, t, l1 = 1, · · · , N1,
k = 1, · · · , nj and j = 1, · · · , 10, and K1 =
∑m
j=1 nj.
• We generate Q1,l1,ijk independently from Poisson(λ).
• The counting frame observation for the (l1, i)th subject is (Q1,l1,i11 , · · · , Q1,l1,i1,n1 , · · · , Q1,l1,i10,1 , · · · ,
Q1,l1,i10,n10),
• The stereological estimate Nˆ 1,l1,i for the (l1, i)th subject is estimated directly from (2.1),
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Table 4.2: Simulation Parameter List
L (mm) 25
m 10
(Area1, · · · , Aream)
(mm2)
(204.8, 230.4, 256.0, 281.6, 307.2, 307.2, 281.6, 256.0,
230.4, 204.8)
a2f (µm
2) 512
h (µm) 30
au = av (mm) 1.131
α 0.05
β 0.20
δ(106) 20
σB(10
12) 400
λ0 0.636
N 20
K1 2000
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Nˆ 1,l1,i = 1
τsτaτh
10∑
j=1
nj∑
k=1
Q1,l1,ijk
=
Laxay
mha2f
10∑
j=1
nj∑
k=1
Q1,l1,ijk .
Note σB is fixed by the example.
• To generate the primary outcomes, the biological variability (4.8) should be taken into
account. To do so we generate a random number 1,l1,i independently from N(0, σB),
and add that value to the stereological estimate Nˆ 1,l1,i to obtain the primary outcome
Nˆ ∗1,l1,i, that is
Nˆ ∗1,l1,c = Nˆ 1,l1,c + 1,l1,c,
Nˆ ∗1,l1,t = Nˆ 1,l1,t + 1,l1,t.
Note, in reality, the data we obtain in the Stage I is Nˆ ∗1,l1,i which includes the biological
variation, and Nˆ 1,l1,i is never known. One wary to actually generate the data is using
the random intensity λ for each subject. The variation of the intensity would be the
source of the biological variance. However, since such a simulation is under Cruz-Orive
and Geiser assumption where the counting frame data follows a Poisson distribution,
the validity of normality distribution assumption in (4.8) would be in doubt. In our
adaptation procedure, since our focus is to re-estimate the stereological variance, we use
the approximation of adding the biological variance to the stereological estimators of the
neuron number to avoid the conflict with distribution assumption of primary outcome.
• The two components of the stereological variance of the simulated stereological sample
are calculated based on formula (2.20) and (2.27) in Chapter 2,
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σˆ1,l1,ist1,K1 =
1
240τ 2s τ
2
a τ
2
h
(
3
10∑
j=1
(Q1,l1,ij )
2 +
8∑
j=1
Q1,l1,ij Q
1,l1,i
j+2 − 4
9∑
j=1
Q1,l1,ij Q
1,l1,i
j+1
)
=
L2a2ua
2
v
240m2h2a4f
(
3
10∑
j=1
(Q1,l1,ij )
2 +
8∑
j=1
Q1,l1,ij Q
1,l1,i
j+2 − 4
9∑
j=1
Q1,l1,ij Q
1,l1,i
j+1
)
,
σˆ1,l1,ist2,K1 =
1
τ 2s τ
2
a τ
2
h
10∑
j=1
Q1,l1,ij
=
L2a2ua
2
v
m2h2a4f
10∑
j=1
Q1,l1,ij ,
where Q1,l1,ij (=
∑nj
k=1Q
1,l1,i
jk ) is the sum of the counted neuron in j
th section for subject
l1 in group i.
At the end of Stage I, use the average of the 2 · N1 stereological variance estimates as
the estimated stereological variance for each component,
σ̂st1,K1 =
∑
i=c,t
∑N1
l1=1
σˆ1,l1,ist1,K1
2N1
,
σ̂st2,K1 =
∑
i=c,t
∑N1
l1=1
σˆ1,l1,ist2,K1
2N1
.
Then we can calculate the number of counting frames of the second stage (K2) based on
(4.23) with the two components of the stereological variance σ̂st1,K1 and σ̂st2,K1 . Thus, K2
solves the power equation
1− β = P (|T | > t1−α/2, bdf |n̂cp),
where
n̂cp(K2) =
δ√
N1
N2
[2(σB + σ̂st1,K1 + σ̂st2,K1)] +
N2
N2
[2(σB + σ̂st1,K1 +
K1
K2
σ̂st2,K1)]
,
and estimated degrees of freedom
d̂f(K2) =
[
N1
N2
(σB + σ̂st1,K1 + σ̂st2,K1) +
N2
N2
(σB + σ̂st1,K1 +
K1
K2
σ̂st2,K1)
]2
(
N1
N2
)2 (σB+bσst1,K1+bσst2,K1 )2
N1−1 +
(
N2
N2
)2 (σB+bσst1,K1+K1K2 bσst2,K1 )2
N2−1
.
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Then, we generate the counting frame data for Stage II with N2 = N −N1 pairs.
Stage II Simulation In Stage II, the counted number Q2,l2,ijk is also from Poisson distribution
with same λ, where l2 = 1, · · · , N2, and the steps are essentially the same as Stage I, except
the number of counting frames is adjusted.
• We generate Q2,l2,ijk independently from Poisson(λ).
• The counting frame observation for the (l2, i)th subject is (Q2,l2,i11 , · · · , Q2,l2,i1,K2
K1
n1
, · · · , Q2,l2,i10,1 ,
· · · , Q2,l2,i
10,
K2
K1
n10
).
• The stereological estimate Nˆ 2,l2,i for the (l2, i)th subject is estimated directly from (2.1),
Nˆ 2,l2,i = 1
τsτaτh
10∑
j=1
K2
K1
nj∑
k=1
Q2,l2,ijk
=
Laxay
mha2f
10∑
j=1
K2
K1
nj∑
k=1
Q2,l2,ijk .
• To generate the primary outcomes, the biological variability is again accounted for, and
we generate random numbers 2,l2,i independently from N(0, σB) and appropriately add
them to obtain the primary outcomes.
Combining Stage At the end of Stage II, we calculate the p-value for the stereological
study based on the combined data sets of (Nˆ ∗1,l1,c, Nˆ ∗1,l1,t) and (Nˆ ∗2,l2,c, Nˆ ∗2,l2,t), where the
test statistic is defined by (4.20).
This process is repeated 1000 times, so that the type I error rate of our procedure is
estimated by the proportion of p-value less than α = 0.05. The average number of counting
frames K2 is also obtained. Table 4.3 gives the estimated type I error rates for different true
λ’s and varying values of N1, the Stage I sample size. No substantive impact of λ and N1
on the type I error rate is found in this simulation study.
4.3.6.2 Power The power under blinded adaptive procedure can be obtained analogously
to the type I error rate by simulation. Under the alternative hypothesis, the population
numbers of neuron in the control and experimental groups are different , so that the two
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Table 4.3: Simulation – Type I Error Rate (1000 times, λ0 = 0.636)
N1
λ = 0.4 λ = 0.5 λ = 0.6 λ = 0.7
α K2 α K2 α K2 α K2
5 0.052 1083 0.048 1445 0.047 1866 0.051 2369
6 0.046 1050 0.049 1417 0.045 1857 0.046 2398
7 0.051 1012 0.051 1386 0.048 1845 0.049 2435
8 0.053 972 0.053 1352 0.051 1834 0.056 2479
9 0.048 929 0.046 1312 0.052 1821 0.049 2538
10 0.052 881 0.053 1270 0.047 1808 0.051 2605
11 0.047 831 0.048 1219 0.045 1787 0.053 2693
12 0.051 774 0.042 1164 0.053 1763 0.047 2818
13 0.047 711 0.053 1097 0.049 1732 0.050 2990
14 0.045 642 0.051 1020 0.046 1696 0.044 3259
15 0.046 565 0.048 930 0.051 1646 0.048 3732
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groups have different true population intensities. In simulating the power, we assume that
the true population intensities of neurons in each counting frame for treatment and control
group are λt and λc, respectively. Since
δ = µc − µt
=
1
τsτaτh
m∑
j=1
njλc − 1
τsτaτh
m∑
j=1
njλt
=
L
mha2f
[
m∑
j=1
Areaj
]
(λc − λt), (4.27)
the difference of the two intensities has a proportional relationship with the alternative δ.
According to (4.27), the difference of λc and λt is
δ
L
mha2
f
Pm
j=1 Areaj
, which is independent
of the number of counting frames. In our simulation, we assume the alternative δ is 20 ∗ 106,
then
λc − λt = δL
mha2f
∑m
j=1 Areaj
=
20 ∗ 106
25∗103
10∗30∗512 ∗ 2560 ∗ 106
= 0.05.
On the other hand, the overall mean density for the paired study is
λ =
λc + λt
2
.
Then we select the following pairs of parameters (λc = 0.425, λt = 0.375), (λc =
0.525, λt = 0.475), (λc = 0.625, λt = 0.575) and (λc = 0.725, λt = 0.625). The power is
estimated by the proportion of times that we reject the null hypothesis in 1000 tests. The
expected number of counting frames is very similar as the number we obtained in type I
error rate simulations.
We also generate the counting frame data for each subject of treatment and control
groups from Poisson distribution with λt and λc, respectively. However, all other parameters
remain the same including σB and N1. Table 4.4-4.7 give the desired power of the study
under the alternative. Consider the case when the true λ is 0.4 so that there is about a
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60% over-estimate of the intensity parameter used in the planning stage. If there are 5 pairs
of subjects in Stage I, we find that on average 1083 counting frames are required in Stage
II, which is about 55% of the number used in Stage I. If we followed the original design
without an adaptation, the number of counting frames is 80000, while the average number
of counting frames is 52490 in our procedure. On the other hand, when the initial guess of
λ is too low, the number of counting frames is required to be increased to maintain power.
When the true λ is 0.8, there is about a 20% under-estimate of the intensity parameter used
in the design. If there are 5 pairs of subjects in Stage I, we find that on the average 2975
counting frames are required in Stage II in order to obtain the desired power, which is about
50% increase of number used in Stage I. This increase in the numbers of counting frames
occurs because the original design is under powered.
Table 4.4: Simulation - Power 1 (λc = 0.425, λt = 0.375)
N1 5 6 7 8 9 10 11 12 13 14 15
Power 0.833 0.825 0.829 0.818 0.845 0.836 0.827 0.826 0.797 0.825 0.815
K2 1084 1048 1012 972 929 882 830 774 711 642 566
Table 4.5: Simulation - Power 2 (λc = 0.525, λt = 0.475)
N1 5 6 7 8 9 10 11 12 13 14 15
Power 0.830 0.849 0.815 0.823 0.800 0.808 0.816 0.823 0.814 0.839 0.814
K2 1445 1417 1387 1351 1313 1269 1220 1163 1097 1021 930
75
Table 4.6: Simulation - Power 3 (λc = 0.625, λt = 0.575)
N1 5 6 7 8 9 10 11 12 13 14 15
Power 0.844 0.817 0.822 0.827 0.831 0.844 0.832 0.816 0.811 0.826 0.817
K2 1866 1858 1847 1835 1821 1806 1787 1762 1734 1696 1645
Table 4.7: Simulation - Power 4 (λc = 0.725, λt = 0.675)
N1 5 6 7 8 9 10 11 12 13 14 15
Power 0.819 0.838 0.823 0.831 0.828 0.849 0.817 0.841 0.828 0.823 0.828
K2 2367 2397 2433 2480 2536 2603 2694 2819 2994 3264 3737
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5.0 CONCLUSIONS AND FUTURE WORK
In Chapter 2, we develop a new procedure based on the Ammeter process for estimating the
variance of the fractionator estimator obtained using uniformly systematic sampling. The
assumption for our approach is that the density of the neurons is a random variable instead
of being a constant. In fact, the distribution of neurons in the brain region is always non-
homogenous. The Konopaske data shows the evidence of the overdispersed Poisson process.
We also compare the stereological variance estimator using the Ammeter method with the
estimators obtained by Cruz-Orive and Geiser’s method and the Bootstrap method.
In Chapter 3, we consider experimental design for a stereological study. We develop
procedures for planning a cost efficient study considering two types of optimization. For the
standard paired studies designed for CCNMD, the research aim is to compare the number of
neurons between two groups instead of evaluating individuals’ neuron numbers. We provide
an algorithm to find the the number of subjects and the number of counting frames that
minimize the cost function while maintaining sufficient power to address the research aim.
We also consider an algorithm to maximize statistical power for a fixed budget.
In Chapter 4, we introduce the idea of adaptive design to stereological studies. For the
optimal designs considered in Chapter 3, we require the information about the magnitudes of
the true stereological variance. Stereological variances vary from study to study. It is usually
difficult to pre-specify before a study which is interested in a particular type of neurons. We
apply the approach of blinded adaptive design procedures to stereological studies specially
to the case of a fixed number of subjects pairs, but where we can change the number of
sampling frames. We develop an approach which at the end of Stage I allows us to update
the assumption about the stereological variance used in the planning stage. Based on the
update, we change the number of counting frames to be used in Stage II. We propose an
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adjusted t-statistic to use for hypothesis testing at the end of the study. Simulation is used
to show that the type I error rate of our procedure is protected, and also appropriate power
is maintained.
5.1 FUTURE WORK
5.1.1 Adjusting Both the Counting Frames and Group Size of Stage II (K2 and
N2)
In the future, we will consider the situation that the number of pairs can also be adjusted.
Both K2 and N2 will be allowed to depend on Stage I data. The difference D¯ =
1
N
[(N1X¯1 +
N2X¯2)− (N1Y¯1 +N2Y¯2)] then will have data dependent weights. The adjusted t-statistic we
proposed in (4.21) may not be appropriate to use.
Then, we would consider an alternative test statistic, which is a combination of Z-
statistics,
Z =
√
φZ1 +
√
1− φZ2, (5.1)
where Z1 and Z2 are the Z-statistics for Stage I and Stage II respectively, and φ is a pre-
specified constant. This test statistic has a normal distribution and type I error rate is
guaranteed. However, the strategy to pick φ need to be discussed. Under the alternative,
Z ∼ N(ξ, 1), where ξ = √φ δr
2σB+σ
c
st,K1
+σt
st,K1
N1
+
√
1− φ δr
2σB+σ
c
st,K2
+σt
st,K2
N2
.
Consider the total cost for the study:
Cost = C0 + 2C1N + 2C2N1K1 + 2C2N2K2
= (C0 + 2C1N1 + 2C2N1K1) + 2C1N2 + 2C2N2K2
= C∗0 + 2C1N2 + 2C2N2K2. (5.2)
where C∗0 = C0 + 2C1N1 + 2C2N1K1. The cost of the first stage is fixed with fixed (N1, K1),
so that to obtain an optimal design we need to optimize the second stage.
We plan to develop the strategy to pick K2 and N2 as part of our future research goals.
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5.1.2 Ammeter assumption validity
We estimated the stereological variance under the Ammeter assumption in Chapter 2. How-
ever, the assumption’s validity has to be checked. We note that the assumption of an
Ammeter process can be compared to a Poisson model using a likelihood ratio test. To do
this, we use α = 1/φ in the NB distribution. Because α→ 0 implies that the NB distribution
goes to a Poisson distribution, the validity test can be represented as testing α = 0.
5.1.3 Matched Triads Design
Dr. Konopaske uses a triads study to detect the antipsychotic exposure effect on the number
of glial cells. Due to the unequal stereological variances among groups under the alternative
hypothesis, to apply the adaptive procedure in designing a triads study is more complex.
Furthermore, the two components of the stereological variance can’t be estimated by blinded
data. The unblinded approach may be considered in triads case. We will examine this
situation more carefully in the future.
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APPENDIX A
SYSTEMATIC DELETION
A.1 SYSTEMATIC DELETION OF DATA SET WITH 20% REDUCTION
Table A1: Comparing the Original Data Set and 45 Samples with 20% Reduction
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Sample1 -27.9 13.55 -2.06 0.033
Sample2 -27.4 13.03 -2.10 0.031
Sample3 -26.6 13.28 -2.01 0.036
Sample4 -24.5 13.54 -1.81 0.050
Sample5 -25.6 13.60 -1.89 0.044
Sample6 -27.0 13.93 -1.93 0.041
Sample7 -27.6 14.21 -1.94 0.040
Sample8 -27.2 13.75 -1.98 0.038
Sample9 -24.3 12.65 -1.92 0.042
Sample10 -27.0 12.47 -2.16 0.028
Sample11 -26.2 12.72 -2.06 0.033
Sample12 -24.1 12.99 -1.85 0.047
Sample13 -25.2 13.07 -1.93 0.041
Sample14 -26.5 13.34 -1.99 0.037
Sample15 -27.2 13.63 -1.99 0.037
Sample16 -26.8 13.19 -2.03 0.035
Sample17 -23.9 12.07 -1.98 0.038
Sample18 -25.7 12.13 -2.12 0.030
Sample19 -23.6 12.51 -1.88 0.044
Sample20 -24.7 12.58 -1.97 0.039
Sample21 -26.0 12.79 -2.04 0.034
Sample22 -26.7 13.20 -2.02 0.035
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A1: (continued) Comparing the Original Data Set and 45 Samples with 20% Reduction.
Dataset Estimate StdErr t-stat p-value
Sample23 -26.3 12.62 -2.09 0.032
Sample24 -23.4 11.60 -2.02 0.036
Sample25 -22.8 12.69 -1.80 0.051
Sample26 -24.0 12.83 -1.87 0.046
Sample27 -25.3 13.05 -1.94 0.041
Sample28 -25.9 13.34 -1.94 0.040
Sample29 -25.6 12.94 -1.98 0.038
Sample30 -22.6 11.82 -1.91 0.042
Sample31 -21.8 13.17 -1.66 0.064
Sample32 -23.1 13.38 -1.73 0.057
Sample33 -23.8 13.75 -1.73 0.057
Sample34 -23.4 13.19 -1.77 0.053
Sample35 -20.5 12.19 -1.68 0.062
Sample36 -24.3 13.42 -1.81 0.050
Sample37 -24.9 13.83 -1.80 0.051
Sample38 -24.6 13.30 -1.85 0.047
Sample39 -21.6 12.28 -1.76 0.054
Sample40 -26.2 14.02 -1.87 0.045
Sample41 -25.9 13.55 -1.91 0.043
Sample42 -22.9 12.40 -1.85 0.047
Sample43 -26.5 13.78 -1.92 0.042
Sample44 -23.6 12.80 -1.84 0.048
Sample45 -23.2 12.32 -1.89 0.044
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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A.2 SYSTEMATIC DELETION OF DATA SET WITH 30% REDUCTION
Table A2: Comparing the Original Data Set and 120 Samples with 30% Reduction
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Sample1 -29.2 13.11 -2.23 0.025
Sample2 -28.3 13.42 -2.11 0.031
Sample3 -25.8 13.63 -1.90 0.044
Sample4 -27.2 13.68 -1.99 0.038
Sample5 -28.7 14.14 -2.03 0.035
Sample6 -29.4 14.39 -2.04 0.034
Sample7 -29.0 13.94 -2.08 0.032
Sample8 -25.6 12.62 -2.03 0.035
Sample9 -27.7 12.72 -2.18 0.027
Sample10 -25.3 13.07 -1.93 0.041
Sample11 -26.6 13.12 -2.03 0.035
Sample12 -28.1 13.49 -2.08 0.032
Sample13 -28.8 13.89 -2.07 0.032
Sample14 -28.4 13.27 -2.14 0.029
Sample15 -25.1 12.06 -2.08 0.032
Sample16 -24.4 13.29 -1.84 0.048
Sample17 -25.7 13.42 -1.92 0.042
Sample18 -27.2 13.81 -1.97 0.038
Sample19 -27.9 14.06 -1.99 0.037
Sample20 -27.5 13.66 -2.02 0.036
Sample21 -24.2 12.34 -1.96 0.039
Sample22 -23.3 13.73 -1.70 0.060
Sample23 -24.8 14.10 -1.76 0.055
Sample24 -25.5 14.46 -1.76 0.054
Sample25 -25.1 13.86 -1.81 0.050
Sample26 -21.7 12.67 -1.71 0.059
Sample27 -26.1 14.10 -1.85 0.047
Sample28 -26.8 14.52 -1.85 0.047
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Table A2: (continued) Comparing the Original Data Set and 120 Samples with 30% Reduc-
tion.
Dataset Estimate StdErr t-stat p-value
Sample29 -26.4 13.95 -1.89 0.044
Sample30 -23.1 12.74 -1.81 0.050
Sample31 -28.3 14.86 -1.90 0.043
Sample32 -27.9 14.37 -1.94 0.040
Sample33 -24.6 13.01 -1.89 0.044
Sample34 -28.6 14.56 -1.97 0.039
Sample35 -25.3 13.40 -1.89 0.044
Sample36 -24.9 12.90 -1.93 0.041
Sample37 -27.3 12.10 -2.25 0.024
Sample38 -24.8 12.46 -1.99 0.037
Sample39 -26.1 12.53 -2.09 0.032
Sample40 -27.6 12.82 -2.15 0.028
Sample41 -28.3 13.25 -2.14 0.029
Sample42 -27.9 12.64 -2.21 0.026
Sample43 -24.6 11.41 -2.15 0.028
Sample44 -23.9 12.68 -1.89 0.044
Sample45 -25.3 12.83 -1.97 0.039
Sample46 -26.8 13.15 -2.03 0.035
Sample47 -27.5 13.41 -2.05 0.034
Sample48 -27.1 13.04 -2.08 0.032
Sample49 -23.7 11.70 -2.03 0.035
Sample50 -22.8 13.15 -1.73 0.057
Sample51 -24.3 13.45 -1.81 0.051
Sample52 -25.0 13.82 -1.81 0.050
Sample53 -24.6 13.24 -1.86 0.046
Sample54 -21.3 12.05 -1.76 0.054
Sample55 -25.6 13.47 -1.90 0.043
Sample56 -26.3 13.90 -1.89 0.044
Sample57 -25.9 13.35 -1.94 0.040
Sample58 -22.6 12.13 -1.86 0.046
Sample59 -27.8 14.18 -1.96 0.039
Sample60 -27.4 13.71 -2.00 0.037
Sample61 -24.1 12.32 -1.96 0.040
Sample62 -28.1 13.90 -2.03 0.035
Sample63 -24.8 12.73 -1.95 0.040
Sample64 -24.4 12.25 -1.99 0.037
Sample65 -23.4 12.04 -1.94 0.040
Sample66 -24.7 12.18 -2.03 0.035
Sample67 -26.2 12.40 -2.11 0.030
Sample68 -26.9 12.83 -2.10 0.031
Sample69 -26.5 12.28 -2.16 0.028
Sample70 -23.2 11.04 -2.10 0.031
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Table A2: (continued) Comparing the Original Data Set and 120 Samples with 30% Reduc-
tion.
Dataset Estimate StdErr t-stat p-value
Sample71 -22.2 12.65 -1.76 0.055
Sample72 -23.7 12.85 -1.85 0.047
Sample73 -24.4 13.38 -1.83 0.049
Sample74 -24.0 12.62 -1.90 0.043
Sample75 -20.7 11.55 -1.79 0.052
Sample76 -25.1 12.87 -1.95 0.040
Sample77 -25.8 13.46 -1.92 0.042
Sample78 -25.4 12.73 -1.99 0.037
Sample79 -22.0 11.64 -1.89 0.044
Sample80 -27.3 13.64 -2.00 0.037
Sample81 -26.9 13.00 -2.07 0.033
Sample82 -23.5 11.71 -2.01 0.036
Sample83 -27.6 13.34 -2.07 0.033
Sample84 -24.2 12.29 -1.97 0.038
Sample85 -23.8 11.63 -2.05 0.034
Sample86 -21.4 12.86 -1.66 0.064
Sample87 -22.9 13.09 -1.75 0.056
Sample88 -23.6 13.47 -1.75 0.055
Sample89 -23.2 12.93 -1.79 0.052
Sample90 -19.8 11.74 -1.69 0.061
Sample91 -24.2 13.19 -1.83 0.048
Sample92 -24.9 13.62 -1.83 0.049
Sample93 -24.5 13.12 -1.87 0.046
Sample94 -21.2 11.91 -1.78 0.053
Sample95 -26.4 13.82 -1.91 0.043
Sample96 -26.0 13.41 -1.94 0.041
Sample97 -22.7 12.01 -1.89 0.044
Sample98 -26.7 13.59 -1.97 0.039
Sample99 -23.4 12.42 -1.88 0.045
Sample100 -23.0 12.00 -1.91 0.042
Sample101 -21.7 13.58 -1.60 0.070
Sample102 -22.4 14.11 -1.59 0.071
Sample103 -22.0 13.41 -1.64 0.066
Sample104 -18.7 12.35 -1.51 0.081
Sample105 -23.9 14.31 -1.67 0.063
Sample106 -23.5 13.69 -1.72 0.058
Sample107 -20.2 12.45 -1.62 0.068
Sample108 -24.2 13.98 -1.73 0.057
Sample109 -20.9 12.97 -1.61 0.069
Sample110 -20.5 12.33 -1.66 0.064
Sample111 -25.3 14.33 -1.76 0.054
Sample112 -24.9 13.75 -1.81 0.050
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Table A2: (continued) Comparing the Original Data Set and 120 Samples with 30% Reduc-
tion.
Dataset Estimate StdErr t-stat p-value
Sample113 -21.5 12.48 -1.72 0.058
Sample114 -25.6 14.10 -1.81 0.050
Sample115 -22.2 13.06 -1.70 0.060
Sample116 -21.8 12.46 -1.75 0.055
Sample117 -27.1 14.35 -1.89 0.044
Sample118 -23.7 13.13 -1.81 0.050
Sample119 -23.3 12.61 -1.85 0.047
Sample120 -24.0 12.94 -1.86 0.046
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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APPENDIX B
BOOTSTRAP DELETION
B.1 BOOTSTRAP DELETION OF DATA SET WITH 10% REDUCTION
Table B1: Comparing the Original Data Set and 50 Bootstrap Samples with 10% Reduction
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Bootstrap1 -25.0 15.12 -1.66 0.064
Bootstrap2 -28.7 12.28 -2.34 0.021
Bootstrap3 -27.5 14.25 -1.93 0.041
Bootstrap4 -29.1 13.31 -2.19 0.027
Bootstrap5 -29.0 12.74 -2.28 0.023
Bootstrap6 -23.4 10.82 -2.16 0.028
Bootstrap7 -23.6 12.88 -1.83 0.049
Bootstrap8 -29.8 15.14 -1.97 0.039
Bootstrap9 -23.4 12.04 -1.95 0.040
Bootstrap10 -26.6 13.77 -1.93 0.041
Bootstrap11 -24.0 12.70 -1.89 0.044
Bootstrap12 -23.5 10.85 -2.17 0.028
Bootstrap13 -29.7 11.07 -2.69 0.011
Bootstrap14 -25.2 11.44 -2.20 0.026
Bootstrap15 -24.5 13.38 -1.83 0.049
Bootstrap16 -29.7 14.15 -2.10 0.031
Bootstrap17 -29.6 13.90 -2.13 0.029
Bootstrap18 -23.3 13.38 -1.74 0.056
Bootstrap19 -22.2 12.04 -1.84 0.047
Bootstrap20 -26.7 14.40 -1.86 0.046
Bootstrap21 -29.7 13.84 -2.14 0.029
Bootstrap22 -28.1 12.99 -2.16 0.028
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B1: (continued) Comparing the Original Data Set and 50 Bootstrap Samples with 10% Re-
duction.
Dataset Estimate StdErr t-stat p-value
Bootstrap23 -25.0 12.06 -2.07 0.033
Bootstrap24 -28.6 13.39 -2.14 0.029
Bootstrap25 -27.8 14.22 -1.95 0.040
Bootstrap26 -27.7 11.48 -2.41 0.018
Bootstrap27 -29.4 14.16 -2.07 0.032
Bootstrap28 -26.7 13.36 -2.00 0.037
Bootstrap29 -26.1 14.72 -1.78 0.053
Bootstrap30 -26.4 13.37 -1.97 0.038
Bootstrap31 -25.9 14.03 -1.85 0.047
Bootstrap32 -26.0 13.58 -1.91 0.042
Bootstrap33 -29.5 13.20 -2.23 0.025
Bootstrap34 -24.3 13.73 -1.77 0.054
Bootstrap35 -25.8 12.81 -2.02 0.036
Bootstrap36 -22.9 11.39 -2.01 0.036
Bootstrap37 -30.7 13.53 -2.27 0.023
Bootstrap38 -30.1 13.92 -2.16 0.028
Bootstrap39 -28.2 13.25 -2.13 0.030
Bootstrap40 -23.5 13.86 -1.70 0.060
Bootstrap41 -31.2 11.81 -2.64 0.012
Bootstrap42 -25.8 12.01 -2.14 0.029
Bootstrap43 -26.0 13.02 -1.99 0.037
Bootstrap44 -23.8 13.01 -1.83 0.049
Bootstrap45 -25.8 13.43 -1.92 0.042
Bootstrap46 -32.3 12.68 -2.55 0.014
Bootstrap47 -31.7 12.90 -2.45 0.017
Bootstrap48 -25.0 12.75 -1.96 0.039
Bootstrap49 -22.7 11.21 -2.02 0.035
Bootstrap50 -26.4 12.79 -2.07 0.033
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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B.2 BOOTSTRAP DELETION OF DATA SET WITH 20% REDUCTION
Table B2: Comparing the Original Data Set and 50 Bootstrap Samples with 20% Reduction
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Bootstrap1 -24.3 13.44 -1.81 0.050
Bootstrap2 -26.3 14.37 -1.83 0.048
Bootstrap3 -30.0 15.05 -1.99 0.037
Bootstrap4 -28.6 13.23 -2.16 0.028
Bootstrap5 -26.7 12.51 -2.14 0.029
Bootstrap6 -25.7 13.32 -1.93 0.041
Bootstrap7 -27.4 13.68 -2.01 0.036
Bootstrap8 -26.6 13.73 -1.93 0.041
Bootstrap9 -23.8 12.27 -1.94 0.040
Bootstrap10 -24.9 14.19 -1.75 0.055
Bootstrap11 -26.6 13.24 -2.01 0.036
Bootstrap12 -26.3 14.30 -1.84 0.048
Bootstrap13 -28.8 12.76 -2.25 0.024
Bootstrap14 -24.9 11.19 -2.22 0.025
Bootstrap15 -22.7 15.21 -1.50 0.083
Bootstrap16 -23.8 12.20 -1.95 0.040
Bootstrap17 -31.4 13.84 -2.27 0.023
Bootstrap18 -24.6 12.23 -2.01 0.036
Bootstrap19 -29.1 13.18 -2.21 0.026
Bootstrap20 -26.9 12.80 -2.10 0.031
Bootstrap21 -29.4 12.67 -2.32 0.021
Bootstrap22 -25.5 13.22 -1.93 0.041
Bootstrap23 -32.0 12.29 -2.60 0.013
Bootstrap24 -26.8 15.37 -1.75 0.056
Bootstrap25 -28.7 14.77 -1.95 0.040
Bootstrap26 -29.8 11.78 -2.53 0.015
Bootstrap27 -22.2 12.12 -1.83 0.049
Bootstrap28 -29.7 14.48 -2.05 0.034
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Table B2: (continued) Comparing the Original Data Set and 50 Bootstrap Samples with 20%
Reduction.
Dataset Estimate StdErr t-stat p-value
Bootstrap29 -25.4 13.85 -1.83 0.048
Bootstrap30 -24.2 12.03 -2.01 0.036
Bootstrap31 -23.6 11.64 -2.03 0.035
Bootstrap32 -25.0 13.07 -1.91 0.042
Bootstrap33 -28.1 12.76 -2.20 0.026
Bootstrap34 -21.5 11.68 -1.84 0.047
Bootstrap35 -21.5 13.73 -1.57 0.074
Bootstrap36 -28.4 11.28 -2.52 0.015
Bootstrap37 -29.2 13.78 -2.12 0.030
Bootstrap38 -22.7 13.06 -1.74 0.056
Bootstrap39 -25.9 14.19 -1.83 0.049
Bootstrap40 -26.6 13.38 -1.99 0.037
Bootstrap41 -22.9 12.35 -1.86 0.046
Bootstrap42 -31.0 15.08 -2.05 0.034
Bootstrap43 -27.7 12.82 -2.16 0.028
Bootstrap44 -27.2 13.88 -1.96 0.039
Bootstrap45 -23.6 15.27 -1.55 0.076
Bootstrap46 -32.1 12.99 -2.47 0.016
Bootstrap47 -30.4 12.89 -2.36 0.020
Bootstrap48 -24.7 15.29 -1.61 0.069
Bootstrap49 -27.7 12.20 -2.27 0.023
Bootstrap50 -23.0 11.72 -1.97 0.039
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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B.3 BOOTSTRAP DELETION OF DATA SET WITH 30% REDUCTION
Table B3: Comparing the Original Data Set and 50 Bootstrap Samples with 30% Reduction
Dataset Estimate StdErr t-stat p-value
Original -25.0 12.94 -1.93 0.0413
Bootstrap1 -23.9 12.06 -1.98 0.038
Bootstrap2 -27.1 13.51 -2.01 0.036
Bootstrap3 -26.8 14.73 -1.82 0.049
Bootstrap4 -21.3 13.01 -1.64 0.066
Bootstrap5 -27.0 13.07 -2.07 0.033
Bootstrap6 -23.3 10.74 -2.17 0.027
Bootstrap7 -24.9 14.06 -1.77 0.053
Bootstrap8 -26.2 13.40 -1.95 0.040
Bootstrap9 -26.3 13.42 -1.96 0.039
Bootstrap10 -31.9 14.37 -2.22 0.025
Bootstrap11 -27.0 11.82 -2.28 0.023
Bootstrap12 -30.9 14.07 -2.20 0.026
Bootstrap13 -23.7 12.83 -1.84 0.048
Bootstrap14 -25.3 10.89 -2.33 0.021
Bootstrap15 -27.7 12.62 -2.19 0.027
Bootstrap16 -23.3 12.16 -1.91 0.042
Bootstrap17 -26.8 13.98 -1.91 0.042
Bootstrap18 -30.8 14.88 -2.07 0.033
Bootstrap19 -23.5 12.36 -1.90 0.043
Bootstrap20 -29.4 13.92 -2.11 0.031
Bootstrap21 -35.3 12.76 -2.77 0.010
Bootstrap22 -26.8 14.03 -1.91 0.043
Bootstrap23 -24.7 13.54 -1.82 0.049
Bootstrap24 -26.6 12.69 -2.10 0.031
Bootstrap25 -31.2 15.66 -1.99 0.037
Bootstrap26 -24.7 12.80 -1.93 0.041
Bootstrap27 -24.6 11.97 -2.05 0.034
Bootstrap28 -35.2 16.57 -2.12 0.030
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Table B3: (continued) Comparing the Original Data Set and 50 Bootstrap Samples with 30%
Reduction.
Dataset Estimate StdErr t-stat p-value
Bootstrap29 -26.5 12.34 -2.14 0.029
Bootstrap30 -27.0 12.56 -2.15 0.029
Bootstrap31 -25.7 12.65 -2.03 0.035
Bootstrap32 -19.1 12.06 -1.59 0.072
Bootstrap33 -25.5 14.16 -1.80 0.051
Bootstrap34 -32.1 14.51 -2.21 0.026
Bootstrap35 -24.7 11.74 -2.10 0.031
Bootstrap36 -25.6 13.31 -1.93 0.042
Bootstrap37 -24.6 12.71 -1.94 0.041
Bootstrap38 -27.7 12.89 -2.15 0.029
Bootstrap39 -22.5 13.08 -1.72 0.058
Bootstrap40 -26.4 12.98 -2.04 0.035
Bootstrap41 -31.2 12.69 -2.46 0.017
Bootstrap42 -18.9 14.43 -1.31 0.110
Bootstrap43 -29.2 12.04 -2.43 0.018
Bootstrap44 -29.0 14.91 -1.94 0.040
Bootstrap45 -26.0 14.10 -1.84 0.048
Bootstrap46 -20.7 12.21 -1.69 0.061
Bootstrap47 -27.0 13.08 -2.06 0.033
Bootstrap48 -26.7 11.15 -2.40 0.019
Bootstrap49 -27.8 13.06 -2.13 0.030
Bootstrap50 -29.9 15.49 -1.93 0.041
Note: The degree of the t statistics is 10 and the p-value is based on a one-sided testing.
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